TW200948860A - Liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element - Google Patents

Liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element Download PDF

Info

Publication number
TW200948860A
TW200948860A TW98103132A TW98103132A TW200948860A TW 200948860 A TW200948860 A TW 200948860A TW 98103132 A TW98103132 A TW 98103132A TW 98103132 A TW98103132 A TW 98103132A TW 200948860 A TW200948860 A TW 200948860A
Authority
TW
Taiwan
Prior art keywords
formula
liquid crystal
crystal alignment
group
alignment agent
Prior art date
Application number
TW98103132A
Other languages
Chinese (zh)
Other versions
TWI438226B (en
Inventor
Kohei Goto
Noritoshi Miki
Kenzo Yada
Masaaki Katayama
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of TW200948860A publication Critical patent/TW200948860A/en
Application granted granted Critical
Publication of TWI438226B publication Critical patent/TWI438226B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1042Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0273Polyamines containing heterocyclic moieties in the main chain
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1046Polyimides containing oxygen in the form of ether bonds in the main chain
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1046Polyimides containing oxygen in the form of ether bonds in the main chain
    • C08G73/105Polyimides containing oxygen in the form of ether bonds in the main chain with oxygen only in the diamino moiety
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • C08G73/1078Partially aromatic polyimides wholly aromatic in the diamino moiety

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Provided is a liquid-crystal alignment material capable of giving a liquid-crystal alignment film which has a high voltage retention and which, even after having been exposed to a high-temperature atmosphere over long, is reduced in residual charge accumulated by direct-current voltage. Also provided is a liquid-crystal display element employing the liquid-crystal alignment film. The liquid-crystal alignment material comprises a copolymer obtained by reacting a diamine ingredient comprising at least one diamine compound (A) and a diamine compound (B) with a tetracarboxylic dianhydride. Diamine compound (A): at least one compound selected from the group consisting of compounds of the formulae [T1], [T2], and [T3], which are diamine compounds having a tertiary nitrogen atom. Diamine compound (B): a diamine compound having a carboxy group in the molecule. (Chemical formula 1) [T1] [T2] [T3] (In the formulae [T1] to [T3], W1 is a benzene ring or nitrogenous aromatic heterocycle; W2 is an aromatic group having 6 to 15 carbon atoms and having one or two benzene rings; W3 is C2-5 alkylene or biphenylene; W4 is cycloalkylene having 4 to 6 carbon atoms and substituted by a tertiary nitrogen atom; W5 is C2-5 alkylene; Z1 is amino substituted by two C1-6 aliphatic groups when W1 is a benzene ring, or Z1 is hydrogen or amino substituted by two C1-6 aliphatic groups when W1 is a nitrogenous aromatic heterocycle; Z2 is C1-5 alkyl or a benzene ring; and g is an integer of 0 or 1.)

Description

200948860 六、發明說明: 【發明所屬之技術領域】 本發明爲有關製作液晶配向膜時所使用之液晶配向劑 及使用其之液晶顯示元件之發明。 【先前技術】 目前’液晶顯示元件之液晶配向膜主要係使用將以聚 φ 醯胺酸等之聚醯亞胺前驅物或可溶性聚醯亞胺之溶液作爲 主要成份之液晶配向劑(亦稱爲液晶配向劑)塗佈於玻璃 基板上並經燒成而成之所謂的聚醯亞胺系液晶配向膜。 液晶配向膜係爲了控制液晶之配向狀態之目的而使用 者。然而,伴隨著液晶顯示元件之高精細化,由於液晶顯 示元件之對比降低之抑制或殘像顯像降低之要求,使得使 用之液晶配向膜中須提高電壓維持率,或施加直流電壓時 減少殘留電荷,及/或提早緩和因直流電壓而累積之殘留 Ο 電荷之特性亦逐漸變得重要。 聚醯亞胺系液晶配向膜中,作爲使因直流電壓產生之 .殘像消失之前之時間縮短者,已知有使用除聚醯胺酸或含 .有醯亞胺之聚醯胺酸以外含有特定結構之三級胺之液晶配 向劑者(例如參照專利文獻1 ),或使用於原料使用具有 赃啶骨架等之特定二胺之可溶性聚醯亞胺之液晶配向劑者 (例如參照專利文獻2 )。另外,作爲使電壓維持率高且 因直流電壓產生之殘像消失之前之時間縮短者,已知有使 用除聚醯胺酸或其醯亞胺化聚合物等以外含有極少量之選 -5- 200948860 自分子內含有1個羧基之化合物、分子內含有1個羧酸酐 基之化合物及分子內含有1個三級胺基之化合物之化合物 之液晶配向劑者(例如參照專利文獻3)。 然而,近年來大畫面且高精細之液晶電視已廣爲實用 化,該等用途之液晶顯示元件中,與迄今爲止主要顯示文 字或靜止畫面之顯示器用途相比較,相對於殘量之要求更 爲嚴苛,且要求有在過度嚴苛之使用環境下之耐長期使用 之特性。據此,所使用之液晶配向膜亦要求有比過去更高 之信賴性,且關於液晶配向膜之電特性不僅亦要求良好之 初期特性,亦要求有例如即使在高溫下長時間暴露後亦可 維持良好之特性。 [專利文獻1]特開平9-316200號公報 [專利文獻2]特開平10-104633號公報 [專利文獻3]特開平8-76128號公報 【發明內容】 本發明即是鑒於上述情事所提出者。即,本發明所欲 解決之問題爲,提供一種可得到高電壓保持率,且即使於 長時間暴露於高溫下時,也僅有少許因直流電壓所蓄積之 殘留電荷之液晶配向膜的液晶配向劑。 此外’本發明並提供一種於嚴苛使用環境下也可耐長 期使用之具有高信賴性之液晶顯示元件。 本發明者,爲達上述目的而經過深入硏究結果,發現 可達成該目的之液晶配向劑。本發明爲基於該結果所得者 -6 - 200948860 ,其具有以下之特徵。 (1) 一種含有包含二胺化合物(A)及二胺化合物( B)之二胺成份與四羧酸二酐反應所得之共聚物之液晶配 向劑。 二胺化合物(A):下述之具有三級氮原子之二胺化 合物之由式[T1] '式[T2]及式[T3]所成群中所選出之至少 一種之化合物, 二胺化合物(B ):分子內具有羧基之二胺化合物, [化1][Technical Field] The present invention relates to a liquid crystal alignment agent used in the production of a liquid crystal alignment film and a liquid crystal display element using the same. [Prior Art] At present, the liquid crystal alignment film of the liquid crystal display element mainly uses a liquid crystal alignment agent which is mainly composed of a solution of a polyfluorene imine or the like of polyφ lysine or a soluble polyimine (also referred to as a liquid crystal alignment agent). A liquid crystal alignment agent is a so-called polyimine-based liquid crystal alignment film which is applied onto a glass substrate and fired. The liquid crystal alignment film is used for the purpose of controlling the alignment state of the liquid crystal. However, with the high refinement of the liquid crystal display element, the suppression of the contrast reduction of the liquid crystal display element or the reduction of the residual image development requires the voltage maintenance ratio to be increased in the liquid crystal alignment film to be used, or the residual charge is reduced when a DC voltage is applied. , and / or early mitigation of the residual Ο charge due to DC voltage characteristics have gradually become important. In the polyimine-based liquid crystal alignment film, as long as the time until the afterimage disappears due to the DC voltage is shortened, it is known to use a polyglycine other than the polyaminic acid or the phthalimide. A liquid crystal alignment agent of a tertiary amine having a specific structure (for example, refer to Patent Document 1), or a liquid crystal alignment agent using a soluble polyimine of a specific diamine having an acridine skeleton or the like as a raw material (for example, refer to Patent Document 2) ). In addition, as a result of shortening the time until the residual voltage due to the DC voltage is high and the voltage retention rate is high, it is known to use a very small amount of -5- except for polyacrylic acid or its ruthenium iodide polymer. 200948860 A liquid crystal alignment agent containing a compound having one carboxyl group in the molecule, a compound containing one carboxylic acid anhydride group in the molecule, and a compound containing one compound of a tertiary amino group in the molecule (for example, see Patent Document 3). However, in recent years, large-screen and high-definition liquid crystal televisions have been widely put into practical use, and liquid crystal display elements for such applications are more demanding than the remaining ones in comparison with display applications that have mainly displayed characters or still pictures. It is demanding and requires long-term use in an environment of excessively harsh use. Accordingly, the liquid crystal alignment film used also requires higher reliability than in the past, and the electrical characteristics of the liquid crystal alignment film not only require good initial characteristics, but also require, for example, long-term exposure even at high temperatures. Maintain good characteristics. [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei No. Hei 8- No. Hei. No. Hei. . That is, the problem to be solved by the present invention is to provide a liquid crystal alignment of a liquid crystal alignment film which can obtain a high voltage holding ratio and which has only a small amount of residual electric charge accumulated by a DC voltage even when exposed to a high temperature for a long period of time. Agent. Further, the present invention provides a liquid crystal display element which is highly resistant to long-term use in a severe use environment. The inventors of the present invention have found in order to achieve the above objective, and have found a liquid crystal alignment agent which can achieve the object. The present invention is based on the result -6 - 200948860, which has the following features. (1) A liquid crystal alignment agent containing a copolymer obtained by reacting a diamine component of a diamine compound (A) and a diamine compound (B) with a tetracarboxylic dianhydride. Diamine compound (A): a compound of at least one selected from the group consisting of the formula [T1] 'Formula [T2] and the formula [T3] of a diamine compound having a tertiary nitrogen atom, a diamine compound (B): a diamine compound having a carboxyl group in the molecule, [Chemical Formula 1]

(式[T1]至式[T3]中’ Wi爲苯環或含氮芳香族雜環, W2爲具有6至15個碳原子,且具有1至2個苯環之芳香 © 族基,W3爲碳數2至5之伸烷基或聯苯撐,w4爲可被3 紱氮原子所取代之碳原子數4至6之伸環烷基,W5爲碳 數2至5之伸烷基,Z!爲,Wi爲苯環之情形時爲碳數1 至6之可被脂肪族基所取代之二取代胺基,W!爲含氮芳 香族雜環之情形時爲可被氫原子或碳數1至6之脂肪族基 所取代之二取代胺基,Z2爲碳數1至5之烷基或苯環,g 爲0或1之整數)。 (2 )如上述(1 )記載之液晶配向劑,其中,二胺化 合物(A)爲下述之式[1]至式[4]所表示之化合物。 200948860(In the formula [T1] to the formula [T3], 'Wi is a benzene ring or a nitrogen-containing aromatic hetero ring, and W2 is an aromatic group having 6 to 15 carbon atoms and having 1 to 2 benzene rings, W3 is a 2 to 5 carbon alkyl or biphenylene, w4 is a 4- to 6-membered cycloalkyl group which may be substituted by a 3 fluorene nitrogen atom, and W5 is a C 2 to 5 alkyl group, Z. In the case where Wi is a benzene ring, a disubstituted amine group having a carbon number of 1 to 6 which may be substituted by an aliphatic group, and a case where a nitrogen-containing aromatic heterocyclic ring is used may be a hydrogen atom or a carbon number. A disubstituted amino group substituted with an aliphatic group of 1 to 6, Z2 is an alkyl group having 1 to 5 carbon atoms or a benzene ring, and g is an integer of 0 or 1. (2) The liquid crystal alignment agent according to the above (1), wherein the diamine compound (A) is a compound represented by the following formula [1] to formula [4]. 200948860

(式Π]至式[4]中’ Al爲含氮芳香族雜環’ A2爲具有 6至15個碳原子’且具有1至2個苯環之芳香族基’A3 爲碳數2至5之伸烷基或聯苯撐,A*爲式[4 a]或式[4b]所 表示之基,As爲碳數2至5之伸院基,Υι爲这碳數1至6 之脂肪族基所取代之二取代胺基,Y2爲碳數1至5之院基 或苯環,k爲〇或1之整數)。 (3 )如上述(2 )記載之液晶配向劑,其中,二胺化 合物(A)爲式Π]或式[2]。 (4)如上述(2)記載之液晶配向劑,其中,式[3]之 A2爲苯環或下述之式[3a], [:化 3] 〇(Formula Π] to [4] where 'Al is a nitrogen-containing aromatic heterocyclic ring' A2 is an aromatic group having 6 to 15 carbon atoms' and having 1 to 2 benzene rings 'A3 is a carbon number 2 to 5 The alkyl group or the biphenylene group, A* is a group represented by the formula [4 a] or the formula [4b], As is a base group having a carbon number of 2 to 5, and Υ is an aliphatic group having 1 to 6 carbon atoms. The disubstituted amine group substituted by a group, Y2 is a phenyl or a benzene ring having a carbon number of 1 to 5, and k is an anthracene or an integer of 1). (3) The liquid crystal alignment agent according to the above (2), wherein the diamine compound (A) is a formula or a formula [2]. (4) The liquid crystal alignment agent according to the above (2), wherein A2 of the formula [3] is a benzene ring or the following formula [3a], [:3]

P -0 [3 a] (式[3 a]中,P爲由單鍵、-〇-、-NH-、伸甲基,及醯 胺基所選出之鍵結基)。 -8 - 200948860 (5)如上述(1)或上述(2)記載之液晶配向劑, 其中’一胺化合物(A )爲由下述之式[5]至[18]所成群所 選出之至少一種之二胺化合物, [化4] © [5] [6] [7] [8]P -0 [3 a] (In the formula [3 a], P is a bond group selected from a single bond, -〇-, -NH-, a methyl group, and a fluorenyl group). The liquid crystal alignment agent according to the above (1) or (2), wherein the 'monoamine compound (A) is selected from the group consisting of the following formulas [5] to [18]. At least one diamine compound, [4] [5] [6] [7] [8]

[17] [18] 200948860 (式[13]中,m、η分別爲1至11之整數’ m + n爲2 至12之整數,式[15]中,j爲〇至3之整數,式[18]中,h 爲1至5之整數)。 (6 )如上述(1 )至上述(5 )中任一項記載之液晶 配向劑’其中’二胺化合物(B)爲下述之式[19]所表示 之二胺化合物。 [化7] (fOOH)n i Cl 9] /Xi、 Η/ ΝΗ2 (式[19]中,Χι爲碳數6至30之具有芳香族環之有 機基,η爲1至4之整數)。 (7 )如上述(6 )記載之液晶配向劑,其中,二胺化 合物(Β)爲由下述之式[20]至式[24]所選出之二胺化合物 [化8][17] [18] 200948860 (in the formula [13], m and η are integers from 1 to 11 respectively] m + n is an integer from 2 to 12, and in the formula [15], j is an integer from 〇 to 3, In [18], h is an integer from 1 to 5.) (6) The liquid crystal alignment agent according to any one of the above (1), wherein the 'diamine compound (B) is a diamine compound represented by the following formula [19]. (fOOH)n i Cl 9] /Xi, Η/ ΝΗ2 (In the formula [19], Χι is an organic group having an aromatic ring of 6 to 30 carbon atoms, and η is an integer of 1 to 4). (7) The liquid crystal alignment agent according to the above (6), wherein the diamine compound (Β) is a diamine compound selected from the following formula [20] to formula [24].

200948860 (式[2 0]中,ml爲1至4之整數,式[21]中,X2爲單 鍵、-CH2·、-C2ί^4"、_C(CH3)2、-CF2、-C(CF3)2_、-0_ 、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH20-、 OCH2-、-COO-、-OCO-、-CON(CH3)-,或 _N(CH3)CO·, m2、m3分S!l爲〇至4之整數,且m2 + m3表示1至4之整 數,式[22]中,m4、m5分別爲1至5之整數,式[23]中, 0 X3爲碳數1至5之直鏈或支鏈烷基,m6爲1至5之整數 、式[24]中,X4 爲單鍵、-CH2-、-C2H4-、-C(CH3)2-、 -CF2-、-C(CF3)2-、-〇-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCH〗-、-COO-、-OCO-、 -CON(CH3)-,或-N(CH3)CO-,m7 爲 1 至 4 之整數)。 (8 )如上述(7 )記載之液晶配向劑,其中,式[20] 中,ml爲1至2之整數。 (9)如上述(7)記載之液晶配向劑,其中,式[21] ❹ 中,x2 爲單鍵、-(:112-、-(:2114-、-(:((:113)2-、-0-、-(:0-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-COO-,或-OCO-,m2、m3同時爲1之整數。 (1 0 )如上述(7 )記載之液晶配向劑,其中,式[24] 中,爲單鍵、-CH2-、-0-、-CO-、-ΝΗ-、-CONH-、 -NHCO-、-CH20-、-OCH2-、-COO-,或-OCO· ’ m7 爲 1 至2之整數。 (11)如上述(1)至上述(1〇)中任一項記載之液 晶配向劑,其中,二胺成份中之二胺化合物(B)之含量 -11 - 200948860 爲相對於二胺化合物(A)之1莫耳,爲0.01至99莫耳 〇 (12)如上述(1)至上述(11)中任一項記載之液 晶配向劑,其中,液晶配向劑中所含之溶劑中之5至80 質量%爲弱溶劑。 (1 3 )如上述(1 )至上述(12 )中任一項記載之液 晶配向劑,其中,液晶配向劑中之共聚物爲聚醯胺酸經脫 水閉環所得之聚醯亞胺。 (14) —種液晶配向膜,其特徵爲,使用上述(1) 至上述(13)中任一項記載之液晶配向劑所得者。 (15) —種液晶顯示元件,其特徵爲,具有上述(14 )記載之液晶配向膜。 本發明之液晶配向處理劑,可以較簡便之方法製得, 本發明之液晶配向劑,可得到具有高電壓保持率,且即使 於長時間暴露於高溫下時,僅有少許因直流電壓所蓄積之 殘留電荷之液晶配向膜。因此,本發明之液晶配向劑所得 之具有液晶配向膜之液晶顯示元件,具有優良之信賴性, 而極適合被使用於大畫面且具有高精細度之液晶電視。 [發明實施之最佳形態] 本發明爲有關含有包含二胺化合物(A)及二胺化合 物(B)之二胺成份與四羧酸二酐反應所得之共聚物的液 晶配向劑,使用該液晶配向劑所得之液晶配向膜’及具有 該液晶配向膜之液晶顯示元件。 -12- 200948860 <二胺成份> 本發明所使用之二胺化合物(A),爲具有式[T1]至 式[T3]所表示之3級氮原子之二胺化合物。本發明中之3 級氮原子,係指氮原子之3個鍵結鍵爲氫原子以外之原子 ,較佳爲與碳原子鍵結之氮原子之意。 本發明所使用之二胺化合物(A)之3級氮原子’因 φ 其共軛結構而具有電子跳躍(hopping-site )之機能’於 液晶配向膜中,可促進電荷之移動。又,前述3級氮原子 ,與二胺化合物(B)於其分子中所具有之羧基,經由形 成鹽或氫鍵結之静電相互作用連結,而於3級氮原子與羧 基之間引起電荷之移動。因此,所蓄積之電荷可有效率的 於共聚物之分子內、分子間進行移動。 即,本發明之液晶配向劑,於作爲液晶配向膜之際, 可得到具有高電壓保持率,且即使於長時間暴露於高溫下 ❹ 時,僅有少許因直流電壓所蓄積之殘留電荷之液晶配向膜 [二胺化合物(A)] 本發明所使用之二胺化合物(A),爲由下述之式 [T1]、式[T2]及式[T3]所成群中所選出之至少一種化合物 ,爲具有3級氮原子之二胺化合物。 -13- 200948860 [化9]200948860 (in the formula [2 0], ml is an integer from 1 to 4, and in the formula [21], X2 is a single bond, -CH2·, -C2ί^4", _C(CH3)2, -CF2, -C( CF3)2_,-0_, -CO-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -CH20-, OCH2-, -COO-, -OCO-, -CON(CH3) -, or _N(CH3)CO·, m2, m3, S!l is an integer from 〇 to 4, and m2 + m3 represents an integer from 1 to 4, and in the formula [22], m4 and m5 are 1 to 5, respectively. An integer, in the formula [23], 0 X3 is a linear or branched alkyl group having 1 to 5 carbon atoms, m6 is an integer of 1 to 5, and in the formula [24], X4 is a single bond, -CH2-, - C2H4-, -C(CH3)2-, -CF2-, -C(CF3)2-, -〇-, -CO-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -CH2O-, -OCH-, -COO-, -OCO-, -CON(CH3)-, or -N(CH3)CO-, m7 is an integer from 1 to 4. (8) The liquid crystal alignment agent according to the above (7), wherein, in the formula [20], ml is an integer of from 1 to 2. (9) The liquid crystal alignment agent according to (7) above, wherein, in the formula [21] ,, x2 is a single bond, -(:112-, -(:2114-, -(:((:113)2-) , -0-, -(:0-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -COO-, or -OCO-, m2, m3 are integers of 1 at the same time. 0) The liquid crystal alignment agent according to the above (7), wherein, in the formula [24], a single bond, -CH2-, -0-, -CO-, -ΝΗ-, -CONH-, -NHCO-, - A liquid crystal alignment agent according to any one of the above-mentioned (1), wherein the liquid crystal alignment agent of any one of the above-mentioned (1), wherein The content of the diamine compound (B) in the diamine component is -11 - 200948860, which is 0.01 to 99 moles per mole of the diamine compound (A) (12) as described above (1) to (11) above. The liquid crystal alignment agent according to any one of the above (1) to (12) above, wherein the solvent is contained in the liquid crystal alignment agent, and 5 to 80% by mass is a weak solvent. The liquid crystal alignment agent described above, wherein the copolymer in the liquid crystal alignment agent is a polyimine obtained by dehydration ring closure of polyamic acid. (14) A liquid crystal alignment film, The liquid crystal display device of the above (1), which is obtained by the liquid crystal alignment device of the above (14). The liquid crystal alignment treatment agent of the invention can be obtained by a relatively simple method, and the liquid crystal alignment agent of the invention can obtain a high voltage retention ratio, and even when exposed to a high temperature for a long time, only a small amount is accumulated due to a DC voltage. A liquid crystal alignment film having a residual charge. Therefore, the liquid crystal display element having a liquid crystal alignment film obtained by the liquid crystal alignment agent of the present invention has excellent reliability, and is highly suitable for use in a large-screen and high-definition liquid crystal television. BEST MODE FOR CARRYING OUT THE INVENTION The present invention relates to a liquid crystal alignment agent containing a copolymer obtained by reacting a diamine component containing a diamine compound (A) and a diamine compound (B) with a tetracarboxylic dianhydride, using the liquid crystal alignment. A liquid crystal alignment film obtained by the agent and a liquid crystal display element having the liquid crystal alignment film. -12- 200948860 <Diamine component> Diamine compound (A) used in the present invention And a diamine compound having a nitrogen atom of the formula 3 represented by the formula [T1] to the formula [T3]. The nitrogen atom of the third stage in the present invention means that the three bonding bonds of the nitrogen atom are atoms other than the hydrogen atom. Preferably, it is a nitrogen atom bonded to a carbon atom. The nitrogen atom of the diamine compound (A) used in the present invention has a function of hopping-site due to its conjugate structure. In the liquid crystal alignment film, the movement of charges can be promoted. Further, the above-mentioned three-stage nitrogen atom is bonded to the carboxyl group of the diamine compound (B) in its molecule via an electrostatic interaction forming a salt or a hydrogen bond, and causes a charge between the nitrogen atom of the third-order atom and the carboxyl group. Move. Therefore, the accumulated charge can be efficiently moved in the molecule and between molecules of the copolymer. In other words, when the liquid crystal alignment agent of the present invention is used as a liquid crystal alignment film, a liquid crystal having a high voltage holding ratio and having a residual charge accumulated by a DC voltage even when exposed to a high temperature for a long period of time can be obtained. Alignment film [diamine compound (A)] The diamine compound (A) used in the present invention is at least one selected from the group consisting of the following formula [T1], formula [T2], and formula [T3]. The compound is a diamine compound having a nitrogen atom of a 3-stage. -13- 200948860 [化9]

[丁 1][Ding 1]

式[T1]至式[T3]中,W!爲苯環或含氮芳香族雜環’ W2 爲具有6至15個碳原子,且具有1至2個苯環之芳香族 基,W3爲碳數2至5之伸烷基或伸苯基,W4爲可被3級 氮原子所取代之碳原子數4至6之伸環烷基’ 爲碳數2 至5之伸烷基,Zi爲,Wi爲苯環之情形時爲碳數1至6 之可被脂肪族基所取代之二取代胺基,爲含氮芳香族 雜環之情形時爲可被氫原子或碳數1至6之脂肪族基所取 代之二取代胺基,Z2爲碳數1至5之烷基或苯環,g爲〇 或1之整數。 式[T1]至式[T3]所表示之二胺化合物之中’較佳之 化合物,例如下述之式[1]至式[4]之二胺化合物。 [化 10] h2nIn the formula [T1] to the formula [T3], W! is a benzene ring or a nitrogen-containing aromatic heterocyclic ring 'W2 is an aromatic group having 6 to 15 carbon atoms and having 1 to 2 benzene rings, and W3 is carbon a number of 2 to 5 alkyl or phenyl, W4 is a ring alkyl group having 4 to 6 carbon atoms which may be substituted by a nitrogen atom of 3, and a alkyl group having 2 to 5 carbon atoms, Zi is When Wi is a benzene ring, it is a disubstituted amino group having 1 to 6 carbon atoms which may be substituted by an aliphatic group, and in the case of a nitrogen-containing aromatic heterocyclic ring, it may be a hydrogen atom or a fat having 1 to 6 carbon atoms. A disubstituted amino group substituted with a group, Z2 is an alkyl group having 1 to 5 carbon atoms or a benzene ring, and g is an integer of 〇 or 1. Among the diamine compounds represented by the formula [T1] to the formula [T3], preferred compounds are, for example, the diamine compounds of the following formulas [1] to [4]. [化10] h2n

Cl]Cl]

[2] H2N’2、l)l/A3、N^-A2、NH2 [3] h2n[2] H2N'2, l)l/A3, N^-A2, NH2 [3] h2n

h2 [4] [4a] [4b] 式Π]至式[4]中,A!爲含氮芳香族雜環,A2爲具有6 -14- 200948860 至15個碳原子,且具有1至2個苯環之芳香族基’ A3爲 碳數2至5之伸烷基或聯苯撐,a4爲式[4a]或式[4b]所表 示之基’ A5爲碳數2至5之伸烷基,Yi含有3級氮原子 之碳數2至12之脂肪族基,Y2爲碳數1至5之烷基或苯 環,k爲0或1之整數。 〇 式[1]中之Αι爲含氮芳香族雜環,具體而言,例如吡 咯環、咪哇環、噁唑環、噻唑環、吡唑環、吡啶環、嘧啶 環、喹啉環、吡唑啉環、咔唑環、嘌呤環、噻二唑環、嗒 畊環、吡唑啉環、三畊環、吡唑啶環、三唑環、哌啶環、 苯并咪唑環、苯并咪唑環、噻諾啉環、菲啉環、吲哚環、 喹諾啉環、苯并噻唑環、菲噻畊環、噁二唑環及吖啶環, 更好爲吡咯環、咪唑環、噁唑環、噻唑環、吡唑環、吡啶 環、嘧啶環、喹啉環、吡唑啉環,又更好爲吡咯環、咪唑 環、噁唾環' 吡唑環、吡啶環、嘧啶環、喹啉環。具體例 示例如下述之式[5]至式π2]之二胺化合物。H2 [4] [4a] [4b] In the formula [4], A! is a nitrogen-containing aromatic heterocyclic ring, and A2 has 6 to 14-200948860 to 15 carbon atoms and has 1 to 2 The aromatic group 'A3 of the benzene ring is an alkylene group or a biphenylene group having a carbon number of 2 to 5, and a4 is a group represented by the formula [4a] or the formula [4b]. A5 is an alkylene group having 2 to 5 carbon atoms. Yi contains an aliphatic group having 2 to 12 carbon atoms of a nitrogen atom of 3, Y 2 is an alkyl group having 1 to 5 carbon atoms or a benzene ring, and k is an integer of 0 or 1. The oxime in the formula [1] is a nitrogen-containing aromatic heterocyclic ring, specifically, for example, a pyrrole ring, an imidazole ring, an oxazole ring, a thiazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a quinoline ring, and a pyridyl group. Oxazoline ring, oxazole ring, anthracene ring, thiadiazole ring, hydrazine ring, pyrazoline ring, three-till ring, pyrazolidine ring, triazole ring, piperidine ring, benzimidazole ring, benzimidazole Ring, thienoline ring, phenanthroline ring, anthracene ring, quinolino ring, benzothiazole ring, phenothiline ring, oxadiazole ring and acridine ring, more preferably pyrrole ring, imidazole ring, oxazole a ring, a thiazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a quinoline ring, a pyrazoline ring, and more preferably a pyrrole ring, an imidazole ring, a oxacyclic ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a quinoline. ring. Specific Examples Examples are diamine compounds of the following formula [5] to formula π2].

[化 11][化11]

[5] [6] [7] [8][5] [6] [7] [8]

200948860 式[2]中之Υι爲, 肪族基,具體的較佳 胺化合物。 含有3級氮原子之碳數2至I2之脂 .,一,如下述之式[丨3]或式[14]之二 [化 12]200948860 The formula in the formula [2] is an aliphatic group, and a specific preferred amine compound. a lipid having a carbon number of 2 to 12 containing a nitrogen atom of 3, and a formula such as the following formula [丨3] or [14] [Chemical 12]

[13] 式[3]中之A2爲具 個苯環之芳香族基,A γ2爲碳數1至5之烷g 式[3]中之A2,較 [化 13]〇- 式[3a]中,p爲由 基所選出之鍵結基。 式[3]中之較佳具 胺化合物。[13] A2 in the formula [3] is an aromatic group having a benzene ring, and A γ2 is an alkane of a carbon number of 1 to 5, and A2 in the formula [3] is more than [Chemical 13] 〇- [3a] Where p is the bonding group selected by the group. Preferred in the formula [3] is an amine compound.

3爲碳數2至5之伸烷基或伸苯基 基或苯環,k爲〇或1之整數° 佳爲笨環或式[3 a]所表示之結構。 [3 a]3 is an alkylene group having a carbon number of 2 to 5 or a phenyl group or a benzene ring, and k is an integer of 1 or 1. It is preferably a stupid ring or a structure represented by the formula [3 a]. [3 a]

單鍵、_〇·、-NH-、伸甲基,及醯胺 體例,例如下述之式[15]至[17]之二 -16 - 200948860 [化 14]Single bond, _〇·, -NH-, methyl group, and guanamine, such as the following formula [15] to [17] bis -16 - 200948860 [Chem. 14]

h2 h2nH2 h2n

h2 式[13]中,m、n分別爲1至11之整數,m + n爲2至 12之整數,式[15]中,j爲0至3之整數。 式[4]中,A4爲式[4a]或式[4b]所表示之基,A5爲碳數 2至5之伸烷基。 式[4]之較佳具體例,如下述之式[18]之二胺化合物。H2 In the formula [13], m and n are each an integer of 1 to 11, m + n is an integer of 2 to 12, and in the formula [15], j is an integer of 0 to 3. In the formula [4], A4 is a group represented by the formula [4a] or the formula [4b], and A5 is an alkylene group having 2 to 5 carbon atoms. A preferred embodiment of the formula [4] is a diamine compound of the following formula [18].

式[18]中,h爲1至5之整數。 本發明中二胺化合物(A)可單獨使用1種或將複數 種組合使用亦可。 [二胺化合物(B )] 本發明所使用之二胺化合物(B ),分子內具有羧基 -17- 200948860 之二胺化合物。其具體之結構並未有特別限定,較佳爲式 [2]所表示之化合物。 [化 16] Ρη [19]In the formula [18], h is an integer of 1 to 5. In the present invention, the diamine compound (A) may be used singly or in combination of plural kinds. [Diamine compound (B)] The diamine compound (B) used in the present invention has a diamine compound having a carboxyl group of -17-200948860 in its molecule. The specific structure thereof is not particularly limited, and is preferably a compound represented by the formula [2]. [化16] Ρη [19]

HgN’ NH2 式[19]中,X!爲碳數6至30之具有芳香族環之有機 基,η爲1至4之整數。 式[19]之較佳結構’可列舉如下述式[20]至[24]之結 構。 [化 17]HgN' NH2 In the formula [19], X! is an organic group having an aromatic ring having 6 to 30 carbon atoms, and η is an integer of 1 to 4. The preferred structure of the formula [19] can be exemplified by the structures of the following formulas [20] to [24]. [Chem. 17]

2 CO〇H)mi2 CO〇H)mi

(CH2)m4CO〇H(CH2)m4CO〇H

(CH2)m5COOH [2 2] [2 0](CH2)m5COOH [2 2] [2 0]

H2 式[20]中’ ml爲1至4之整數’式[21]中,χ2爲單鍵 ' -CH2- ' -C2H4- ' -C(CH3)2- . -CF2- ^ -C(CF3)2- ' -Ο- ' -CO-、-ΝΗ-、-N(CH3)_、-CONH-、-NHCO-、_Ch2〇-、 -OCH2- > -COO- ' -OCO- . -C〇N(CH3)- - ^-N(CH3)CO-- m2及m3分別爲〇至4之整數,且m2+m3表示1至4之 -18- 200948860 整數,式[22]中,m4及m5分別爲1至5之整數,式[23] 中,X3爲碳數1至5之直鏈或支鏈烷基,m6爲1至5之 整數,式[24]中,X4 爲單鍵、-CH2-、-C2H4·、-C(CH3)2-、-CF^- ' -C(CF3)2-、-〇·、-CO-、-NH-、-N(CH3)-、 -CONH-、-NHCO-、-CH2〇-、-OCH2-、-COO·、-OCO-、 -CON(CH3)-,或-N(CH3)CO-,m7 爲 1 至 4 之整數。H2 In the formula [20], 'ml is an integer from 1 to 4' in the formula [21], χ2 is a single bond '-CH2-'-C2H4-'-C(CH3)2-. -CF2-^-C(CF3 ) 2- ' -Ο- ' -CO-, -ΝΗ-, -N(CH3)_, -CONH-, -NHCO-, _Ch2〇-, -OCH2- > -COO- ' -OCO- . -C 〇N(CH3)- - ^-N(CH3)CO-- m2 and m3 are integers from 〇 to 4, respectively, and m2+m3 represents an integer from 1 to 4 to -18-200948860, in the formula [22], m4 and M5 is an integer of 1 to 5, respectively, and in the formula [23], X3 is a linear or branched alkyl group having 1 to 5 carbon atoms, m6 is an integer of 1 to 5, and in the formula [24], X4 is a single bond, -CH2-, -C2H4·, -C(CH3)2-, -CF^- '-C(CF3)2-, -〇·, -CO-, -NH-, -N(CH3)-, -CONH -, -NHCO-, -CH2〇-, -OCH2-, -COO·, -OCO-, -CON(CH3)-, or -N(CH3)CO-, m7 is an integer from 1 to 4.

較佳爲,式[2 0]中,ml爲1至2之整數結構、式[2 1 中,X2 爲單鍵、-CH2-、-C2H4·、-C(CH3)2-、-0-、 -CO-、-NH-、-N(CH3)-、-CONH-…NHCO-、-COO-,或 -OCO-,m2及m3同時爲1之整數的結構,式[24]中,xPreferably, in the formula [20], ml is an integer structure of 1 to 2, and in the formula [2 1 , X2 is a single bond, -CH2-, -C2H4·, -C(CH3)2-, -0- , -CO-, -NH-, -N(CH3)-, -CONH-...NHCO-, -COO-, or -OCO-, m2 and m3 are both an integer integer structure, in the formula [24], x

爲單鍵、-CH2-、-Ο-、-CO-、-NH-、-CONH-、.NiiCO 之整數 -CH2O-、-OCH2-、-COO-,或-OCO-,m7 爲 1 至 的結構。其中又以式[20]表示之結構爲最佳。 具體例,舉例如下她^ r 逃式[25]至式 (B )之 [35]之化合物 ❹Is a single bond, -CH2-, -Ο-, -CO-, -NH-, -CONH-, .NiiCO integer -CH2O-, -OCH2-, -COO-, or -OCO-, m7 is 1 to structure. Among them, the structure represented by the formula [20] is the best. Specific examples are exemplified by the compounds of [35] to [35] of the formula [25].

[27] [2 8][27] [2 8]

[3 3] H〇〇c[3 3] H〇〇c

〇〇H -19- [31] 200948860 [化 19]〇〇H -19- [31] 200948860 [Chem. 19]

H2H2

COOHCOOH

[34] ih2 式[34]中 ’ X5 爲單鍵、-CH2-、-0-、-CO-、-NH-、 -CONH-、-NHCO-、-CH20-、-OCH2-、-COO-,或-OCO-, 式[35]中,X6 爲單鍵、-CH2-、-0-、-CO-、-NH·、 -CONH-、-NHCO-、-CH20-、-〇CH2-、-COO-,或-OCO-。 [其他二胺化合物] 本發明中,於不損害本發明效果之範圍,可將二胺化 合物(A )、二胺化合物(B )以外之其他二胺化合物作爲 二胺成份合倂使用。其具體例如以下所示。 對一苯二胺、2,3,5,6-四甲基一對—苯二胺、2,5-二甲 基一對-苯二胺、間-苯二胺、2,4-二甲基-間-苯二胺、 2,5-二胺基甲苯、2,6-二胺基甲苯、2,5-二胺基酚、2,4-二 胺基酚、3,5-二胺基酚、3,5-二胺基苄基醇、2,4-二胺基苄 基醇、4,6-二胺基間苯二甲酚、4,4’-二胺基聯苯、3,3’-二 甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、 3,3’-二羥基-4,4’-二胺基聯苯、3,3’-二氟-4,4’-聯苯、3,3’-三氟甲基-4,4’-二胺基聯苯、3,4’-二胺基聯苯、3,3’-二胺 基聯苯、2,2’-二胺基聯苯、2,3’_二胺基聯苯、4,4’-二胺 基二苯基甲烷、3,3’-二胺基二苯基甲烷、3,4’-二胺基二苯 -20- 200948860 基甲烷、2,2’-二胺基二苯基甲烷、2,3’-二胺基二苯基甲烷 、4,4’-二胺基二苯基醚、3,3’-二胺基二苯基醚、3,4’·二 胺基二苯基醚、2,2’-二胺基二苯基醚、2,3’-二胺基二苯基 醚、4,4’-磺醯基二苯胺、3,3’-磺醯基二苯胺、雙(4-胺基 苯基)矽烷、雙(3-胺基苯基)矽烷、二甲基-雙(4-胺基 苯基)矽烷、二甲基-雙(3-胺基苯基)矽烷、4,4’-硫二 苯胺、3,3’-硫二苯胺、4,4’-二胺基二苯基胺、3,3’-二胺 φ 基二苯基胺、3,4’-二胺基二苯基胺、2,2’-二胺基二苯基胺 、2,3’-二胺基二苯基胺、N-甲基(4,4’-二胺基二苯基)胺 、N-甲基(3,3’_二胺基二苯基)胺、N-甲基(3,4’_二胺基 二苯基)胺、N-甲基(2,2’_二胺基二苯基)胺、N-甲基( 2,3’-二胺基二苯基)胺、4,4’-二胺基二苯甲酮、3,3’-二 胺基二苯甲酮、3,4’-二胺基二苯甲酮、1,4-二胺基萘、 2,2’-二胺基二苯甲酮、2,3’-二胺基二苯甲酮、1,5-二胺基 萘、1,6-二胺基萘、1,7-二胺基萘、1,8-二胺基萘、2,5-二 〇 胺基萘、2,6-二胺基萘、2,7-二胺基萘、2,8-二胺基萘、 1.2- 雙(4_胺基苯基)乙烷、1,2-雙(3-胺基苯基)乙烷、 1.3- 雙(4-胺基苯基)丙烷、1,3-雙(3-胺基苯基)丙烷、 1.4- 雙(4-胺基苯基)丁烷、1,4-雙(3-胺基苯基)丁烷、 雙(3,5-二乙基-4-胺基苯基)甲烷、I,4-雙(4-胺基苯氧 基)苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙(4-胺基苯基 )苯、1,3-雙(4_胺基苯基)苯、1,4-雙(4-胺基苄基)苯 、1,3-雙(4-胺基苯氧基)苯、4,4’-[1,4-伸苯基雙(亞甲 基)]二苯胺、4,4’-[1,3-伸苯基雙(亞甲基)]二苯胺、 -21 - 200948860 3,4’-[1,4-伸苯基雙(亞甲基)]二苯胺、3,4’-[1,3-伸苯基 雙(亞甲基)]二苯胺、3,3’-[1,4-伸苯基雙(亞甲基)]二 苯胺、3,3’·[1,3-伸苯基雙(亞甲基)]二苯胺、1,4-伸苯 基雙[(4-胺基苯基)甲烷]、1,4-伸苯基雙[(3-胺基苯基 )甲烷]、1,3-伸苯基雙[(4-胺基苯基)甲烷]、1,3-伸苯 基雙[(3-胺基苯基)甲烷]、1,4-伸苯基雙(4-胺基苯甲酸 酯)、:l,4-伸苯基雙(3-胺基苯甲酸酯)、1,3-伸苯基雙 (4-胺基苯甲酸酯)、1,3-伸苯基雙(3-胺基苯甲酸酯) 、雙(4-胺基苯基)對苯二甲酸酯、雙(3-胺基苯基)對 苯二甲酸酯、雙(4-胺基苯基)間苯二甲酸酯、雙(3-胺 基苯基)間苯二甲酸酯、1^^’-(1,4-伸苯基)雙(4-胺基 苄醯胺)、Ν,Ν’- ( 1,3-伸苯基)雙(4-胺基苄醯胺)、 Ν,Ν’- ( 1,4-伸苯基)雙(3-胺基苄醯胺)、Ν,Ν’- ( 1,3-伸 苯基)雙(3-胺基苄醯胺)、Ν,Ν’- ( 4-胺基苯基)對苯二 甲醯胺、Ν,Ν’- ( 3-胺基苯基)對苯二甲醯胺、Ν,Ν’- ( 4-胺基苯基)間苯二甲醯胺、Ν,Ν’- ( 3-胺基苯基)間苯二 甲醯胺、9,10-雙(4-胺基苯基)蒽、4,4’-雙(4-胺基苯氧 基)二苯基礪、2,2’-雙[4- (4-胺基苯氧基)苯基]丙烷、 2,2雙[4- (4-胺基苯氧基)苯基]六氟丙烷、2,2’-雙(4-胺基苯基)六氟丙烷、2,2’-雙(3-胺基苯基)六氟丙烷、 2,2’-雙(3-胺基-4-甲基苯基)六氟丙烷、2,2’-雙(4-胺基 苯基)丙烷、2,2’-雙(3-胺基苯基)丙烷、2,2’-雙(3-胺 基-4-甲基苯基)丙烷、1,3-雙(4-胺基苯氧基)丙烷、 1,3-雙(3-胺基苯氧基)丙烷、I,4-雙(4-胺基苯氧基)丁 -22- 200948860 烷、1,4-雙(3-胺基苯氧基)丁烷、1,5-雙(4-胺基笨 )戊烷、1,5-雙(3-胺基苯氧基)戊烷、1,6-雙(4、阪 氧基)己烷、1,6-雙(3-胺基苯氧基)己烷、1,7-_ 基苯氧基)庚烷、1,7_雙(3-胺基苯氧基)庚烷、 4 胺 ,8 - $ (4-胺基苯氧基)辛烷、1,8-雙(3-胺基苯氧基)& ^ $烷、 笨氣 (3-垸、 基)申 1,9-雙(4-胺基苯氧基)壬烷、1,9-雙(3-胺基苯> 烷、1,10-雙(4-胺基苯氧基)癸烷、1,10-雙(3-胺基 φ 基)癸烷、1,11-雙(4-胺基苯氧基)十一烷、l,U、_ 胺基苯氧基)十一烷、1,12-雙(4-胺基苯氧基)十 1,12_雙(3-胺基苯氧基)十二烷、雙(4_胺基環己 烷、雙(4-胺基-3-甲基環己基)甲烷、1,3-二胺 费巧辕、 1,4-二胺基丁烷、I,5-二胺基戊烷、1,6-二胺基己餘 !,7. 二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、】, ,1 0、二 胺基癸烷、1,11·二胺基十一烷、1,12_二胺基十二燒等 、 另外,可舉例爲二胺側鏈上具有烷基、含氟燒_ 〇 香環 '脂肪族環、雜環,以及由該等所組成之大壤狀 基之二胺,具體而言可例示爲以下述式[DA1]至式[DA26] 表示之二胺化合物。 [化 20] h2n[34] ih2 In the formula [34], 'X5 is a single bond, -CH2-, -0-, -CO-, -NH-, -CONH-, -NHCO-, -CH20-, -OCH2-, -COO- , or -OCO-, in the formula [35], X6 is a single bond, -CH2-, -0-, -CO-, -NH·, -CONH-, -NHCO-, -CH20-, -〇CH2-, -COO-, or -OCO-. [Other diamine compound] In the present invention, other diamine compounds other than the diamine compound (A) and the diamine compound (B) may be used as a diamine component in a range which does not impair the effects of the present invention. Specifically, it is shown below. p-Toluenediamine, 2,3,5,6-tetramethyl-p-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, m-phenylenediamine, 2,4-dimethyl Base-m-phenylenediamine, 2,5-diaminotoluene, 2,6-diaminotoluene, 2,5-diaminophenol, 2,4-diaminophenol, 3,5-diamine Phenolic, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoisoxoxyl, 4,4'-diaminobiphenyl, 3 , 3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 3,3'-dihydroxy-4, 4'-Diaminobiphenyl, 3,3'-difluoro-4,4'-biphenyl, 3,3'-trifluoromethyl-4,4'-diaminobiphenyl, 3,4' -diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2'-diaminobiphenyl, 2,3'-diaminobiphenyl, 4,4'-diaminodiphenyl Methane, 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenyl-20- 200948860 methyl, 2,2'-diaminodiphenylmethane, 2,3' -diaminodiphenylmethane, 4,4'-diaminodiphenyl ether, 3,3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 2, 2'-Diaminodiphenyl ether, 2,3'-diaminodiphenyl ether 4,4'-sulfonyldiphenylamine, 3,3'-sulfonyldiphenylamine, bis(4-aminophenyl)decane, bis(3-aminophenyl)decane, dimethyl-bis ( 4-aminophenyl)decane, dimethyl-bis(3-aminophenyl)decane, 4,4'-thiodiphenylamine, 3,3'-thiodiphenylamine, 4,4'-diamino Diphenylamine, 3,3'-diamine φ-diphenylamine, 3,4'-diaminodiphenylamine, 2,2'-diaminodiphenylamine, 2,3'- Diaminodiphenylamine, N-methyl(4,4'-diaminodiphenyl)amine, N-methyl(3,3'-diaminodiphenyl)amine, N-methyl (3,4'-diaminodiphenyl)amine, N-methyl(2,2'-diaminodiphenyl)amine, N-methyl (2,3'-diaminodiphenyl) Amine, 4,4'-diaminobenzophenone, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 1,4-diaminonaphthalene , 2,2'-diaminobenzophenone, 2,3'-diaminobenzophenone, 1,5-diaminonaphthalene, 1,6-diaminonaphthalene, 1,7-di Amino naphthalene, 1,8-diaminonaphthalene, 2,5-diamidinonaphthalene, 2,6-diaminonaphthalene, 2,7-diaminonaphthalene, 2,8-diaminonaphthalene, 1.2- double (4_ Phenyl) ethane, 1,2-bis(3-aminophenyl)ethane, 1.3-bis(4-aminophenyl)propane, 1,3-bis(3-aminophenyl)propane , 1.4-bis(4-aminophenyl)butane, 1,4-bis(3-aminophenyl)butane, bis(3,5-diethyl-4-aminophenyl)methane, I,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(4-aminophenyl)benzene, 1,3 - bis(4-aminophenyl)benzene, 1,4-bis(4-aminobenzyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 4,4'-[1 , 4-phenylphenylbis(methylene)]diphenylamine, 4,4'-[1,3-phenylenebis(methylene)]diphenylamine, -21 - 200948860 3,4'-[1 , 4-phenylphenylbis(methylene)]diphenylamine, 3,4'-[1,3-phenylenebis(methylene)]diphenylamine, 3,3'-[1,4-stretch Phenylbis(methylene)]diphenylamine, 3,3'·[1,3-phenylenebis(methylene)]diphenylamine, 1,4-phenylene bis[(4-aminobenzene) Methane], 1,4-phenylene bis[(3-aminophenyl)methane], 1,3-phenylene bis[(4-aminophenyl)methane], 1,3-stretch Phenyl bis[(3-aminophenyl)methane], 1,4- Phenyl bis(4-aminobenzoate), :l,4-phenylphenylbis(3-aminobenzoate), 1,3-phenylenebis(4-aminobenzoic acid) Ester), 1,3-phenylene bis(3-aminobenzoate), bis(4-aminophenyl)terephthalate, bis(3-aminophenyl)-p-phenylene Formate, bis(4-aminophenyl)isophthalate, bis(3-aminophenyl)isophthalate, 1^^'-(1,4-phenylene) Bis(4-Aminobenzylamine), hydrazine, Ν'-(1,3-phenylene)bis(4-aminobenzylamine), hydrazine, Ν'- (1,4-phenylene) Bis(3-aminobenzamide), hydrazine, Ν'-(1,3-phenylene)bis(3-aminobenzylamine), hydrazine, Ν'-(4-aminophenyl) pair Benzoguanamine, hydrazine, Ν'-(3-aminophenyl)-p-xylyleneamine, hydrazine, Ν'-(4-aminophenyl)m-xylyleneamine, hydrazine, hydrazine - (3-Aminophenyl)m-xylyleneamine, 9,10-bis(4-aminophenyl)anthracene, 4,4'-bis(4-aminophenoxy)diphenylanthracene , 2,2'-bis[4-(4-aminophenoxy)phenyl]propane, 2,2 bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2 '-bis(4-amino group Phenyl) hexafluoropropane, 2,2'-bis(3-aminophenyl)hexafluoropropane, 2,2'-bis(3-amino-4-methylphenyl)hexafluoropropane, 2, 2'-bis(4-aminophenyl)propane, 2,2'-bis(3-aminophenyl)propane, 2,2'-bis(3-amino-4-methylphenyl)propane , 1,3-bis(4-aminophenoxy)propane, 1,3-bis(3-aminophenoxy)propane, I,4-bis(4-aminophenoxy)butane-22 - 200948860 Alkane, 1,4-bis(3-aminophenoxy)butane, 1,5-bis(4-aminophenyl)pentane, 1,5-bis(3-aminophenoxy) Pentane, 1,6-bis(4, oxalyl)hexane, 1,6-bis(3-aminophenoxy)hexane, 1,7-phenoxy) heptane, 1, 7_bis(3-aminophenoxy)heptane, 4 amine, 8 - $(4-aminophenoxy)octane, 1,8-bis(3-aminophenoxy) & ^ Alkane, stupid (3-indolyl), 1,9-bis(4-aminophenoxy)decane, 1,9-bis(3-aminobenzene), 1,10-double (4-Aminophenoxy)decane, 1,10-bis(3-aminopentyl)decane, 1,11-bis(4-aminophenoxy)undecane, l, U, _ Aminophenoxy Undecane, 1,12-bis(4-aminophenoxy)decene, 1,12-bis(3-aminophenoxy)dodecane, bis(4-aminocyclohexane, bis(4) -amino-3-methylcyclohexyl)methane, 1,3-diamine, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diamino约余!, 7. Diamino heptane, 1,8-diaminooctane, 1,9-diaminodecane,], 10, diaminodecane, 1,11.diamine Further, it may be exemplified that the diamine has an alkyl group, a fluorine-containing oxime ring, an aliphatic ring, a heterocyclic ring, and the like, in the side chain of the diamine. Specifically, the diamine compound represented by the following formula [DA1] to formula [DA26] can be exemplified as the diamine of the large-sized base. [20] h2n

H2 h2n [DAI] [DA2] [DA3]H2 h2n [DAI] [DA2] [DA3]

[DA4][DA4]

[DA 5] (式[DAI]至式[DA5]中,Ri爲碳數1以上22以下之 -23- 200948860 烷基或含氟烷基)。 [化 21] h2n[DA 5] (In the formula [DAI] to the formula [DA5], Ri is a -23-200948860 alkyl group or a fluorine-containing alkyl group having a carbon number of 1 or more and 22 or less. [21] h2n

h2H2

(式[DA6]至式[DA9]中,R2 表示-COO-、-OCO-、 -CONH-、-NHCO-、-CH2-、-Ο-、-CO-或-NH-,R3 表示碳 數1以上22以下之烷基或含氟烷基)。 [化 22](In the formula [DA6] to the formula [DA9], R2 represents -COO-, -OCO-, -CONH-, -NHCO-, -CH2-, -Ο-, -CO- or -NH-, and R3 represents carbon number 1 or more and 22 or less alkyl groups or fluorine-containing alkyl groups). [化22]

H2NH2N

[DA1 0] [DAI 1][DA1 0] [DAI 1]

(式[DA10]至式[DA11]中,R4 表示-0-、-OCH2-、 -CH20-、-COOCH2-或-CH2OCO-,R5 表示碳數 1 以上 22 以下之烷基、烷氧基、含氟烷基或含氟烷氧基)。 -24- 200948860 [化 23](In the formula [DA10] to the formula [DA11], R4 represents -0-, -OCH2-, -CH20-, -COOCH2- or -CH2OCO-, and R5 represents an alkyl group having 1 to 22 or more carbon atoms, an alkoxy group, Fluorinated alkyl or fluoroalkoxy). -24- 200948860 [Chem. 23]

(式[DA12]至式[DA14]中,R6 表示- COO-、-OCO-、 ❿ -CONH-、-NHCO-、-COOCH2-、-CH2OCO-、-CH20-、 -OCH2-或- CH2-,R7表示碳數1以上22以下之院基、院氧 基、含氟烷基或含氟烷氧基)。 [化 24](In the formula [DA12] to the formula [DA14], R6 represents -COO-, -OCO-, ❿-CONH-, -NHCO-, -COOCH2-, -CH2OCO-, -CH20-, -OCH2- or -CH2- R7 represents a hospital base, a hospitaloxy group, a fluorine-containing alkyl group or a fluorine-containing alkoxy group having a carbon number of 1 or more and 22 or less. [Chem. 24]

(式[DA1 5]至式[DA1 6]中,R8 表示-COO-、-OCO-、 -CONH-、-NHCO-、-COOCH2-、-CH2OCO-、-CH20-、 OCH2·、-CH2-、-Ο-或-NH-,R9表示氟、氰基、三氟甲基 、硝基、偶氮基、甲醯基、乙醯基、乙醯氧基或羥基)。 -25- 200948860 [化 25] h2n(In the formula [DA1 5] to the formula [DA1 6], R8 represents -COO-, -OCO-, -CONH-, -NHCO-, -COOCH2-, -CH2OCO-, -CH20-, OCH2., -CH2- , -Ο- or -NH-, R9 represents fluorine, cyano, trifluoromethyl, nitro, azo, methylidene, ethyl hydrazine, ethoxylated or hydroxy). -25- 200948860 [化25] h2n

:h3 [DAI 7] [DAI 8] h2n:h3 [DAI 7] [DAI 8] h2n

[DAI 9] [DA20] [化 26][DAI 9] [DA20] [Chem. 26]

[化 27][化27]

H3 [DA2 5] [DA2 6] -26- 200948860 除此之外,亦可舉例爲以下述式[DA27]表示之二胺基 砂氧院等。 [化 28] h2n—(CH2)3-H3 [DA2 5] [DA2 6] -26- 200948860 In addition, a diamine-based sand chamber represented by the following formula [DA27] can also be exemplified. [28] h2n—(CH2)3-

Si—(CH2)3—nh2 ch3 [DA2 7] (式[DA27]中,m爲i至i〇之整數)。 其他二胺化合物可依據作爲液晶配向膜時之液晶配向 性、電壓維持特性、累積電荷等特性,以一種或混合兩種 以上使用。 &lt;四羧酸二酐&gt; 本發明所使用之四羧酸二酐,只要爲四羧酸二酐之中 φ 的至少一種化合物即可,其具體例如以下所列舉者。 例如’均苯四酸二酐、2,3,6,7·萘四羧酸二酐、 1,2,5,6-萘四羧酸二酐、154,5,8_萘四羧酸二酐、2,3,6,7-蒽 四羧酸二酐、1,2,5,6-蒽四羧酸二酐、3,3,,4,4’-聯苯四羧 酸二酐、2,3,3’,4-聯苯四羧酸二酐、雙(3,4_二羧基苯基 )醚、3,3’,4,4’-二苯甲酮四羧酸二酐、雙(3,4_二羧基苯 基)颯、雙(3,4-二羧基苯基)甲烷、2,2_雙(3,4_二羧基 苯基)丙烷、1,1’ 1,3,3,3-六氟-2,2-雙(3,4-二竣基苯基 )丙院、雙(3,4-二羧基苯基)二甲基矽烷、雙(3,扣二 -27- 200948860 羧基苯基)二苯基矽烷、2,3,4,5-吡啶四羧酸二酐、2,6-雙 (3,4-二羧基苯基)吡啶、3,3’,4,4’-二苯基碾四羧酸二酐 、3,4,9,10-芘四羧酸二酐、1,3-二苯基-i,2,3,4-環丁烷四 羧酸二酐、氧基二苯四羧酸二酐、1,2,3,4 -環丁烷四羧酸 二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸 二酐、1,2,3,4-四甲基-1,2,3,4-環丁院四竣酸二酐、ι,2-二 甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基_1,2,3,4-環丁 烷四羧酸二酐、1,2,3,4-環庚烷四羧酸二酐、2,3,4,5_四氫 呋喃四羧酸二酐、3,4-二羧基-1-環己基琥珀酸二酐、 2,3,5 -三竣基環戊基乙酸二酐、3,4_二翔基- i,2,3,4 -四氫-1-萘號拍酸二酐、雙環[3.3.0]辛院-2,4,6,8 -四殘酸二酐、 雙環[4,3,0]壬烷-2,4,7,9-四羧酸二酐、雙環[4,4,0]癸烷_ 2,4,7,9-四翔酸二酐、雙環[4,4,0]癸院_2,4,8,10-四竣酸二 酐、三環[6.3.0.0&lt;2,6&gt;]~[--烷-3,5,9,11-四羧酸二酐、 1,2,3,4 -丁院四竣酸二酐、4- (2,5 -二氧代四氫呋喃_3_基 )-1,2,3,4-四氫萘-1,2-二羧酸二酐、雙環[2,2,2]辛-7-烯-2,3,5’6-四羧酸二酐、5-(2,5-二氧代四氫呋喃基)-3_甲 基-3-環己烷-1,2-二羧酸二酐、四環[6,2,1,1,0,2,7]癸-4,5,9,10-四羧酸二酐、3,5,6-三羧基原冰片烷_2: 3,5: 6-二羧酸二酐、1,2,4,5-環己烷四羧酸二酐等。 其中又以使用包含由1,2,3,4 -環丁烷四羧酸二酐、 1.2.3.4- 環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、 1.2.3.4- 四甲基-1,2,3,4-環丁烷四羧酸二酐、ι,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-l,2,3,4-環丁烷四 -28- 200948860 羧酸二酐、1,2,3,4-環庚烷四羧酸二酐、2,3,4,5_四氬呋喃 四羧酸二酐、3,4-二羧基-1-環己基琥珀酸二肝、2,3,5_三 竣基環戊基乙酸二酐、3,4-二羧基-12,3,4-四氫萘琥珀 酸二酐、雙環[3.3.0]辛院-2,4,6,8-四竣酸二酐、雙環 [4,3,0]壬烷-2,4,7,9-四羧酸二酐、雙環[4,4,0]癸烷_ 2.4.7.9- 四殘酸二酐、雙環[4,4,0]癸烷_2,4,8,10-四羧酸二 肝、二環[6·3·0·0&lt;2,6&gt;]十一院-3,5,9,11-四翔酸二酐、 〇 1,2,3,4 -丁烷四羧酸二酐、4- ( 2,5·二氧代四氫呋喃-3-基 )-1,2,3,4-四氫萘-1,2-二竣酸二野、雙環[2,2,2]辛-7-嫌_ 2,3,5’ 6 -四羧酸二酐、5-(2,5-二氧代四氫呋喃基)-3_甲 基-3-環己烷-1,2-二羧酸二酐、四環[6,2,nojj]癸_ 4,5,9,10-四羧酸二酐、3,5,6-三羧基原冰片烷-2:3,5:6-二羧酸二酐、1,2,4,5-環己烷四羧酸二酐,及12,4,5-環己 烷四羧酸二酐所成群所選出之至少一種之化合物之四羧酸 二酐爲佳。更佳爲1,2,3,4-環丁烷四羧酸二酐、ι,2,3,4-環 ❹ 戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、3,4_二竣 基-1-環己基琥珀酸二酐、2,3,5-三羧基環戊基乙酸二酐、 雙環[3.3.0]辛烷-2,4,6,8-四羧酸二酐、雙環[4,3,0]壬院_ 2.4.7.9- 四羧酸二酐、雙環[4,4,0]癸烷-2’ 4,7,9-四羧酸 二酐、雙環[4,4,0]癸垸-2,4,8,10-四羧酸二酐、三環 [6·3.〇·〇&lt;2,6&gt;]十—烷-3,5,9,11-四羧酸二酐、1,2,3,4-丁院 四羧酸二酐、4-(2,5 -二氧代四氫呋喃·3 -基)-1,2,3,4 -四 氫萘-1,2-二羧酸二酐、雙環[2,2,2]辛-7-烯-2,3,5,6-四羧酸 二酐、5- (2,5-二氧代四氫呋喃基)-3-甲基-3-環己烷-1,2_ -29- 200948860 二羧酸二酐、四環[6,2,1,1,0,2,7]癸-4,5,9,1〇-四羧酸二酐 、3,5,6-三羧基原冰片烷-2: 3,5: 6-二羧酸二酐、1,2,4,5- 環己烷四羧酸二酐所成群所選出之至少一種之化合物。 上述四羧酸二酐可依據成爲液晶配向膜時之液晶配向 性、電壓保持性、累積電荷等特定,以一種使用或兩種以 上倂用。 〈共聚物&gt; 0 本發明所使用之共聚物爲聚醯胺酸及聚醯亞胺。聚醯 胺酸爲由含有二胺化合物(A)及二胺化合物(B)之二胺 成份’與四羧酸二酐經反應而得之聚醯胺酸。本發明之聚 醯亞胺爲該聚醯胺酸經脫水閉環所得之聚醯亞胺。該聚醯 胺酸及聚醯亞胺中任一者皆適合作爲製得液晶配向劑之共 聚物。 二胺成份中之二胺化合物(A)的含量越多時,可具 有高電壓保持率,且於長時間暴露於高溫下之後,僅有少 ❹ 許因直流電壓所蓄積之殘留電荷。 又’二胺化合物(B)具有可使前述效果再爲提高之 效果。二胺成份中之二胺化合物(B)的含量,以相對於 —•胺化合物(A)之1吴耳’爲〇.〇1至99莫耳爲佳。更 佳爲0.1至50莫耳’最佳爲〇·5至20莫耳,特佳爲0.5 至10莫耳。 本發明’於不損害本發明之效果之範圍,亦可倂用二 胺化合物(A)、二胺化合物(B )以外之其他二胺化合物 -30- 200948860 作爲二胺成份使用。此時所使用之其他二胺化合物之使用 量’相對於二胺化合物(A)之1莫耳,以〇.〇1至1〇莫 耳爲佳,以0.1至5莫耳爲更佳。 [共聚物之製造方法] 本發明所使用之聚醯胺酸,可使用公知之聚合方法而 製得。一般而言,例如使四羧酸二酐與二胺成份於有機溶 〇 劑中進行反應之方法。四羧酸二酐與二胺成份之反應,以 於有機溶劑中比較容易進行,且就不會產生副產物等觀點 而爲較佳。 此時所使用之有機溶劑,只要可溶解所生成之聚醯胺 酸之溶劑即可。以下爲其具體之例示。 舉例爲Ν,Ν-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯啶酮、N-甲基己內醯胺、二甲基亞颯、四甲 基尿素、吡啶、二甲基碾、六甲基亞颯、γ-丁內酯、異丙 © 醇、甲氧基甲基戊醇、二戊烯、乙基戊基酮、甲基壬基酮 '甲基乙基酮、甲基異戊基酮、甲基異丙基酮、甲基溶纖 素 '乙基溶纖素、甲基溶纖素乙酸酯、乙基溶纖素乙酸酯 、丁基卡必醇、乙基卡必醇、乙二醇、乙二醇單乙酸酯、 乙二醇單異丙基醚、乙二醇單丁基醚、丙二醇、丙二醇單 乙酸酯、丙二醇單甲基醚、丙二醇第三丁基醚、二丙二醇 單甲基醚、二乙二醇、二乙二醇單乙酸酯、二乙二醇二甲 基醚、二丙二醇單乙酸酯單甲基醚、二丙二醇單甲基醚、 二丙二醇單乙基醚、二丙二醇單乙酸酯單乙基醚、二丙二 -31 - 200948860 醇單丙基醚、二丙二醇單乙酸酯單丙基醚、3-甲基-3-甲氧 基丁基乙酸酯、三丙二醇甲基醚、3-甲基-3-甲氧基丁醇、 二異丙基醚、乙基異丁基醚、二異丁烯、乙酸戊酯、丁酸 丁酯、丁基醚、二異丁基酮、甲基環己烯、丙基醚、二己 基醚、二噁烷、正己烷、正戊烷、正辛烷、二乙基醚、環 己酮、碳酸乙烯酯、碳酸丙烯酯、乳酸甲酯、乳酸乙酯、 乙酸甲酯、乙酸乙酯、乙酸正丁酯、乙酸丙二醇單乙基醚 、丙酮酸甲酯、丙酮酸乙酯、3-甲氧基丙酸甲酯、3-乙氧 基丙酸甲基乙酯、3-甲氧基丙酸乙酯、3_乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、二 甘醇二甲醚、4-羥基-4-甲基-2-戊酮等。 該等可單獨使用,亦可混合使用。而且,即使無法使 聚醯胺酸溶解之溶劑,在不使產生之聚醯胺酸析出之範圍 內,亦可混合於上述溶劑中使用。另外,有機溶劑中之水 分會妨礙聚合反應,進而成爲使所生成之聚醯胺酸水解之 原因,因此有機溶劑以使用儘可能經脫水乾燥者爲佳。 使四羧酸二酐與二胺成份在有機溶劑中反應時,舉例 爲攪拌使二胺成份分散或溶解於有機溶劑中而成之溶液, 且直接添加四羧酸二酐之方法,或使之分散或溶解於有機 溶劑中而添加之方法;相反地使二胺成份添加於將四羧酸 二酐分散或溶解於有機溶劑中而成之溶液中之方法;交互 添加四羧酸二酐及二胺成份之方法等,亦可使用該等之任 一種方法。另外,四羧酸二酐或二胺成份爲由複數種化合 物構成之情況下,亦可在事先混合之狀態下反應’亦可個 -32- 200948860 別依序反應,進而亦可使個別反應成之低分子量體混合反 應成高分子量體。 該些聚醯胺縮之聚合反應,聚合溫度可選擇自-20 °C至 15(TC之任意溫度,但較佳爲-5°C至l〇〇°C之範圍。另外, 反應可在任意之濃度下進行,但由於濃度太低時難以所得 高分子量之共聚物,濃度太高時反應液體之黏性過高使得 均勻攪拌變得困難,因此四羧酸二酐與二胺成份之反應溶 φ 液中之合計濃度較佳爲1至5 0質量%,更好爲5至3 0質 量%。反應初期可在高濃度下進行,隨後,再追加有機溶 劑。 聚醯胺酸之合成反應中,相對於四羧酸二酐之1莫耳 ,二胺成份之莫耳數以0.8至1.2爲佳。該莫耳比越趨近 於1.0時,可增大生成之聚醯胺酸之分子量。 本發明所使用之聚醯亞胺爲使上述之聚醯胺酸經脫水 閉環所得之聚醯亞胺,其可作爲製得液晶配向膜之聚合物 ◎ 本發明所使用之聚醯亞胺中,醯胺酸基之脫水閉環率 (醯亞胺化率)未必須爲100%,可依據用途或目的做任 意調整。 使聚醯亞胺酸醯亞胺化之方法舉例爲將聚醯胺酸之溶 液直接加熱之熱醯亞胺化,將觸媒添加於聚醯胺酸之溶液 中之觸媒醯亞胺化。 使聚醯胺酸溶液中熱醯亞胺化時之溫度爲100 °c至 40 0°C,較佳爲120 °c至250,且較佳同時將醯亞胺化反應 -33- 200948860 產生之水排除於系統外。 聚醯胺酸之觸媒醯亞胺化可在聚醯胺酸之溶液中添加 鹼性觸媒及酸酐,且在-20至250 °C,較佳在〇至180 °C下 攪拌而進行。鹼性觸媒之量爲醯胺酸基之0.5至30莫耳 倍,較佳爲2至20莫耳倍,酸酐之量爲醯胺酸基之1至 5 〇莫耳倍,較佳爲3至3 0莫耳倍。 至於鹼性觸媒可列舉爲吡啶、三乙胺、三甲基胺、三 丁基胺、三辛基胺等,其中妣啶由於可維持適度的鹼性以 使反應進行而較佳。至於酸酐可舉例爲乙酸酐、偏苯三酸 酐、苯均四甲酸酐等,其中若使用酸酐則反應結束後之純 化變得容易而較佳。由觸媒醯亞胺化之醯亞胺化率可藉由 調節觸媒量及反應溫度、反應時間予以控制。 本發明所使用之聚醯亞胺中,醯胺酸基之脫水閉環率 (醯亞胺化率)未必須爲1 〇 〇 %,可依據用途或目的做任 意調整。最佳爲5 0 %以上。 由聚醯胺酸或聚醯亞胺之反應溶液回收所產生之聚醯 胺酸或聚醯亞胺之情況,可將反應溶液倒入弱溶劑中形成 沉澱。沉澱所使用之弱溶劑可舉例爲甲醇、丙酮、己烷、 丁基溶纖素、庚烷、甲基乙基酮、甲基異丁基酮、乙醇、 甲苯、苯、水等。倒入弱溶劑中而沉殿之聚合物經過濾回 收後’可在常壓或減壓下,於常溫或加熱乾燥。另外,使 沉澱回收之聚合物再溶解於有機溶劑中,重複再沉澱回收 操作2至10次,可減少聚合物中之雜質。此時之弱溶劑 舉例爲例如醇類、酮類、烴等,若使用選自該等之內之三 -34- 200948860 種以上弱溶劑,由於可更進一步的提高純化效率而較佳。 本發明之液晶配向劑中所含聚醯胺酸及聚醯亞胺之分 子量,於考量自其所得之塗膜強度及塗膜形成時之作業性 、塗膜之均勻性之情況下,以GPC (凝膠滲透層析)法測 定之重量平均分子量以5,000至1,000,000較佳,更好爲 1 0,000 S 1 50,000 ° 0 &lt;液晶配向劑&gt; 本發明之液晶配向劑爲製作液晶配向膜所使用之塗佈 液,其主成份爲由形成樹脂被膜之樹脂成份,與溶解該樹 脂成份之有機溶劑所構成。本發明中,前述之樹脂成份, 爲含有由上述本發明所使用之聚醯胺酸及聚醯亞胺所成群 中所選出之至少一種之共聚物的樹脂成份。此時,塗佈液 中之樹脂成份的含量爲1質量%至20質量%,較佳爲2質 量%至1 0質量%。 0 本發明中,前述之樹脂成份,可全部爲本發明所使用 之共聚物,或本發明之共聚物中混合其他之聚合物者亦可 。此時,樹脂成份中之其他聚合物之含量爲0.5質量%至 1 5質量%,較佳爲1質量%至1 0質量1%。 該其他之聚合物,例如,作爲可與四羧酸二酐成份反 應之二胺成份之由使用二胺化合物(A)與二胺化合物(B )以外之二胺所得之聚醯胺酸或聚醯亞胺等。 本發明之液晶配向劑所使用之有機溶劑,只要可溶解 上述樹脂成份之有機溶劑時,則無特別限定。其具體例如 -35- 200948860 以下所列舉之內容。 舉例爲N,N-二甲基甲醯胺、Ν,Ν-二甲基乙醯胺、N-甲基-2-吡咯啶酮、Ν-甲基己內醯胺、2-吡咯啶酮、Ν-乙基 吡咯啶酮、Ν-乙烯基吡咯啶酮、二甲基亞楓、四甲基尿素 、吡啶、二甲基碾、六甲基亞碾、γ-丁內酯、1,3 -二甲基-咪唑啶酮、乙基戊基酮、甲基壬基酮、甲基乙基酮、甲基 異戊基酮、甲基異丙基酮、環己酮、碳酸乙烯酯、碳酸丙 烯酯、二甘醇二甲醚、4-羥基-4-甲基-2-戊酮等。該等之 溶劑可將2種以上混合使用。 聚醯亞胺溶解於有機溶劑之際’爲促進聚醯亞胺之溶 解等目的,可進行加熱處理。加熱溫度過高時,將會有造 成聚醯亞胺分子量降低之情形,故溫度以30至1 00°C爲佳 〇 本發明之液晶配向劑,可含有上述以外之成份亦可。 其例示如於塗佈液晶配向劑之際可提高膜厚均勻性或表面 平滑性之溶劑或化合物,提高液晶配向膜與基板之密著性 之化合物等。 提高膜厚均勻性或表面平滑性之溶劑(弱溶劑)之具 體例舉例爲下列者。 舉例爲例如異丙醇、甲氧基甲基戊醇、甲基溶纖素、 乙基溶纖素、丁基溶纖素、甲基溶纖素乙酸酯、乙基溶纖 素乙酸酯、丁基卡必醇、乙基卡必醇、乙基卡必醇乙酸酯 、乙二醇、乙二醇單乙酸酯、乙二醇單異丙基醚、乙二醇 單丁基醚、丙二醇、丙二醇單乙酸酯、丙二醇單甲基醚、 -36- 200948860 丙二醇第三丁基醚、二丙二醇單甲基醚、二乙二醇、二乙 二醇單乙酸酯、二乙二醇二甲基醚、二丙二醇單乙酸酯單 甲基醚、二丙二醇單甲基醚、二丙二醇單乙基醚、二丙二 醇單乙酸酯單乙基醚、二丙二醇單丙基醚、二丙二醇單乙 酸酯單丙基醚、3-甲基-3-甲氧基丁基乙酸酯、三丙二醇甲 基醚、3-甲基-3-甲氧基丁醇、二異丙基醚、乙基異丁基醚 、二異丁烯、乙酸戊酯、丁酸丁酯、丁基醚、二異丁基酮 〇 、甲基環己烯、丙基醚、二己基醚、1-己醇、正己烷、正 戊烷、正辛烷、二乙基醚、乳酸甲酯、乳酸乙酯、乙酸甲 酯、乙酸乙酯、乙酸正丁酯、乙酸丙二醇單乙基醚、丙酮 酸甲酯、丙酮酸乙酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸 甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸、3 -甲氧基 丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、1-甲氧基-2-丙醇、1-乙氧基-2-丙醇、卜丁氧基-2-丙醇、1-苯氧基-2-丙醇、丙二醇單乙酸酯、丙二醇二乙酸酯、丙二醇-1-單 ❹ 甲基醚-2-乙酸酯、丙二醇-1-單乙基醚-2-乙酸酯、二丙二 醇、2-(2-乙氧基丙氧基)丙醇、乳酸甲酯、乳酸乙酯、 乳酸正丙酯、乳酸正丁酯、乳酸異戊酯等具有低表面張力 之溶劑等。 該些溶劑中,又以丁基溶纖素、丙二醇單甲基醚、乳 酸乙酯爲佳。 該等弱溶劑可單獨使用一種’亦可混合複數種使用。 使用如上述之溶劑時,較佳爲液晶配向劑中所含之全部溶 劑之5至8 0質量%,更好爲2 0至6 0質量%。 -37- 200948860 至於提高膜後均勻性或表面平滑性之化合物舉例爲氟 系界面活性劑、矽氧系界面活性劑、非離子系界面活性劑 等。 更具體而言舉例爲例如F TOP EF301、EF3 03、EF352 (TOKEMU PRODUCT 公司製造)、MEGAFAX F171 、 F173、R-30 (大日本油墨公司製造)、FLUORAD FC430 、FC431 (住友 3M 公司製造)、ASAHIGUARD AG710、 SURFLON S-382 ' SC101、SC102、SC103、SC104、SC105 、SC106(旭硝子公司製造)等。該等界面活性劑之使用 比例相對於液晶配向劑中所含樹脂成份1 〇〇質量份較佳爲 〇.〇1至2質量份,更好爲0.01至1質量份。 提高液晶配向膜與基板之密著性之化合物之具體例舉 例爲以下所示之含有官能性矽烷之化合物或含有環氧基之 化合物等。 舉例爲例如3-胺基丙基三甲氧基矽烷、3-胺基丙基三 乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙 氧基矽烷、N- (2-胺基乙基)-3-胺基丙基三甲氧基矽烷、 N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3_脲基 丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧基 羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙 基三乙氧基矽烷、N-三乙氧基矽烷基丙基三伸乙基三胺、 N-三甲氧基矽烷基丙基三伸乙基三胺、三甲氧基矽烷 基_1,4,7-三氮雜癸烷、1〇_三乙氧基矽烷基-14,7-三氮雜癸 烷、9-三甲氧基矽烷基_3,6_二氮雜壬基乙酸酯、9_三乙氧 -38- 200948860 基矽烷基-3,6-二氮雜壬基乙酸酯、N-苄基-3-胺基 甲氧基矽烷、N-苄基-3-胺基丙基三乙氧基矽烷、&gt; 3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙 烷、N-雙(氧伸乙基)-3-胺基丙基三甲氧基矽烷 (氧伸乙基)-3-胺基丙基三乙氧基矽烷、乙二醇二 油醚、聚乙二醇二縮水甘油醚、丙二醇二縮水甘油 丙二醇二縮水甘油醚、聚丙二醇二縮水甘油醚、新 φ 二縮水甘油醚、1,6-己二醇二縮水甘油醚、丙三醇 甘油醚、2,2 -二溴新戊二醇二縮水甘油醚、1,3,5,6-甘油基-2,4-己二醇、^:^’,^[’-四縮水甘油基-間-二胺、1,3-雙(Ν,Ν-二縮水甘油基胺碁甲基)環 N,N,N’,N’-四縮水甘油基-4,4’-二胺基二苯基甲烷等 使用提高與基板之密著性之化合物時,其使用 於液晶配向劑中所含樹脂成份100質量份,較佳爲 3〇質量份,更好爲1至20質量份。使用量若低於 〇 量份,則無法期待密著性提高之效果,若多於3 0 ,則有液晶配向性變差之情況。 本發明之液晶配向劑中,除上述以外,在不損 明效果之範圍內,於使液晶配向膜之介電率或導電 電性特性改變之目的下,亦可添加介電體或導電物 而,亦可添加成爲液晶配向膜之際提高膜之硬度或 之目的之交聯性化合物。 &lt;液晶配向膜、液晶顯示元件&gt; 丙基三 苯基-氧基矽 、N-雙 縮水甘 醚、三 戊二醇 二縮水 四縮水 二甲苯 己烷、 〇 量相對 0.1至 0」質 質量份 及本發 性等之 質,進 致密度 -39- 200948860 本發明之液晶配向劑塗佈於基板上並燒成之後,以摩 擦處理或光照射等予以配向處理,或於垂直配向用途等未 經配向處理,可作爲液晶配向膜使用。此時,作爲所用之 基板只要是透明性高的基板則無特別限制,而可使用玻璃 基板或丙烯酸基板或聚碳酸酯基板等之塑膠基板等。又, 由製程簡單化之觀點觀之,使用形成有用以驅動液晶之 ITO電極等之基板較佳。又,即使於反射型液晶顯示元件 之僅成爲單面基板之矽晶圓等之不透明物亦可使用,此時 之電極亦可使用鋁等之可反射光之材料。 液晶配向劑之塗佈方法並無特別限制,工業上,一般 爲以網版印刷、平版印刷、軟版印刷、噴墨印刷等進行之 方法。至於其他塗佈方法,有浸漬塗佈、輥塗佈、狹縫塗 佈、旋轉塗佈等,亦可依據目的使用該等。 將液晶配向劑塗佈於基板上後之燒成,可藉由加熱板 等之加熱機構,於50至3 00°C,較佳於80至250 °C進行, 使溶劑蒸發並形成塗膜。燒成後所形成之塗膜厚度,若過 厚則對液晶顯示元件之消耗電力方面不利,若過薄則有液 晶顯示元件之信賴性降低之情況,因此較佳爲5至300nm ,更好爲10至l〇〇nm。液晶於水平配向或傾斜配向時, 燒成後之塗膜以摩擦或偏光紫外線照射等予以處理。 本發明之液晶顯示元件爲藉由上述方法自本發明之液 晶配向劑所得貼附有液晶配向膜之基板後,以習知方法製 作液晶單元,並作爲液晶顯示元件者。 若舉出液晶晶胞製作之一例,可舉例有準備形成有液 -40- 200948860 晶配向膜之一對基板’於其中一基板之液晶配向膜上散佈 隔離材,使液晶配向膜面成爲內側之方式,貼合另一片基 板,減壓注入液晶並封裝之方法,或於散佈隔離材之液晶 配向膜面上滴下液晶後貼合基板並進行封裝之方法等。此 時之隔離材厚度較佳爲1至30 μιη,更好爲2至10 μπι。 如以上,使用本發明之液晶配向劑製作之液晶顯示元 件成爲信賴性優異者,可適當利用於大畫面且高精細之液 @ 晶電視等。 【實施方式】 [實施例] 以下列舉實施例與比較例以更詳細說明本發明’但本 發明之解釋並不受該等實施例之限制。 以下爲表示實施例所使用之化合物之簡稱與結構式° 〇 (四羧酸二酐) CBDA: 1,2,3,4•環丁烷四殘酸二酐 BODA:雙環[3,3,0]辛烷-2,4,6,8-四羧酸二酐 [化 29]Si—(CH2)3—nh2 ch3 [DA2 7] (in the formula [DA27], m is an integer from i to i〇). Other diamine compounds may be used singly or in combination of two or more kinds depending on the characteristics of liquid crystal alignment, voltage maintenance characteristics, and accumulated electric charge when used as a liquid crystal alignment film. &lt;tetracarboxylic dianhydride&gt; The tetracarboxylic dianhydride used in the present invention may be at least one compound of φ among tetracarboxylic dianhydrides, and specific examples thereof are as follows. For example, 'pyromellitic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 1,2,5,6-naphthalenetetracarboxylic dianhydride, 154,5,8-naphthalenetetracarboxylic acid Anhydride, 2,3,6,7-nonanetetracarboxylic dianhydride, 1,2,5,6-fluorene tetracarboxylic dianhydride, 3,3,4,4'-biphenyltetracarboxylic dianhydride, 2,3,3',4-biphenyltetracarboxylic dianhydride, bis(3,4-dicarboxyphenyl)ether, 3,3',4,4'-benzophenonetetracarboxylic dianhydride, Bis(3,4-dicarboxyphenyl)anthracene, bis(3,4-dicarboxyphenyl)methane, 2,2-bis(3,4-dicarboxyphenyl)propane, 1,1' 1,3 , 3,3-hexafluoro-2,2-bis(3,4-dimercaptophenyl)propyl, bis(3,4-dicarboxyphenyl)dimethylnonane, double (3, deducted two - 27- 200948860 Carboxyphenyl)diphenylnonane, 2,3,4,5-pyridinetetracarboxylic dianhydride, 2,6-bis(3,4-dicarboxyphenyl)pyridine, 3,3',4 , 4'-diphenyltricarboxylic dianhydride, 3,4,9,10-decanetetracarboxylic dianhydride, 1,3-diphenyl-i, 2,3,4-cyclobutane tetracarboxylate Acid dianhydride, oxydiphenyltetracarboxylic dianhydride, 1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-cyclopentane tetracarboxylic dianhydride, 1, 2,4,5-cyclohexanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2 , 3,4-cyclobutanine tetradecanoic acid dianhydride, iota, 2-dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-dimethyl-1,2 , 3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-cycloheptane tetracarboxylic dianhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride, 3,4- Dicarboxy-1-cyclohexyl succinic dianhydride, 2,3,5-trimethylcyclopentyl acetic acid dianhydride, 3,4-disyl-i,2,3,4-tetrahydro-1-naphthalene Acidic dianhydride, bicyclo [3.3.0] xinyuan-2,4,6,8-tetraresidic acid dianhydride, bicyclo[4,3,0]nonane-2,4,7,9-tetracarboxylate Acid dianhydride, bicyclo[4,4,0]decane _ 2,4,7,9-tetrapic acid dianhydride, bicyclo[4,4,0] brothel _2,4,8,10-tetraquinone Acid dianhydride, tricyclo[6.3.0.0&lt;2,6&gt;]~[--alkane-3,5,9,11-tetracarboxylic dianhydride, 1,2,3,4-dibutyltetradecanoic acid Dihydride, 4-(2,5-dioxotetrahydrofuran_3_yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic dianhydride, bicyclo[2,2,2] Oct-7-ene-2,3,5'6-tetracarboxylic dianhydride, 5-(2,5-dioxotetrahydrofuranyl)-3-methyl-3-cyclohexane-1,2-di Carboxylic dianhydride, tetracyclo[6,2,1,1,0,2,7]indole-4,5,9,10-tetracarboxylic dianhydride, 3,5,6-tricarboxygalbornane _ 2: 3,5: 6-dicarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride Wait. Among them, the use of 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1.2.3.4-cyclopentane tetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic acid Dihydride, 1.2.3.4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, iota, 2-dimethyl-1,2,3,4-cyclobutanetetracarboxylic acid Dihydride, 1,3-dimethyl-l,2,3,4-cyclobutanetetra-28- 200948860 carboxylic acid dianhydride, 1,2,3,4-cycloheptane tetracarboxylic dianhydride, 2 , 3,4,5_tetrahydrofuran tetracarboxylic dianhydride, 3,4-dicarboxy-1-cyclohexyl succinic acid di-hepatic, 2,3,5-trimethylcyclopentyl acetic acid dianhydride, 3, 4-Dicarboxy-12,3,4-tetrahydronaphthalene succinic dianhydride, bicyclo [3.3.0] xinyuan-2,4,6,8-tetradecanoic dianhydride, bicyclo[4,3,0] Decane-2,4,7,9-tetracarboxylic dianhydride, bicyclo[4,4,0]decane _ 2.4.7.9- tetraresidic acid dianhydride, bicyclo[4,4,0]decane_2 , 4,8,10-tetracarboxylic acid di-hepatic, bicyclo[6·3·0·0&lt;2,6&gt;] eleventh hospital-3,5,9,11-tetrahydro acid dianhydride, hydrazine 1, 2,3,4-butanetetracarboxylic dianhydride, 4-(2,5-dioxotetrahydrofuran-3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-didecanoic acid Di野, bicyclo[2,2,2]oct-7-discriminate _ 2,3,5' 6 -tetracarboxylic dianhydride, 5-(2,5-dioxotetrahydrofuranyl)-3_A Benzyl-3-cyclohexane-1,2-dicarboxylic dianhydride, tetracyclo[6,2,nojj]癸_ 4,5,9,10-tetracarboxylic dianhydride, 3,5,6-three Carboxyl norbornane-2:3,5:6-dicarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, and 12,4,5-cyclohexanetetracarboxylic acid Preferably, the tetracarboxylic dianhydride of at least one compound selected from the group consisting of anhydrides is preferred. More preferably 1,2,3,4-cyclobutanetetracarboxylic dianhydride, iota, 2,3,4-cyclopentane pentane tetracarboxylic dianhydride, 1,2,4,5-cyclohexane Carboxylic dianhydride, 3,4-didecyl-1-cyclohexyl succinic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, bicyclo[3.3.0]octane-2,4, 6,8-tetracarboxylic dianhydride, bicyclo[4,3,0] brothel _ 2.4.7.9- tetracarboxylic dianhydride, bicyclo[4,4,0]nonane-2' 4,7,9- Tetracarboxylic dianhydride, bicyclo[4,4,0]indole-2,4,8,10-tetracarboxylic dianhydride, tricyclo[6·3.〇·〇&lt;2,6&gt;]10— Alkane-3,5,9,11-tetracarboxylic dianhydride, 1,2,3,4-butylene tetracarboxylic dianhydride, 4-(2,5-dioxotetrahydrofuran-3-yl)-1 , 2,3,4-tetrahydronaphthalene-1,2-dicarboxylic dianhydride, bicyclo[2,2,2]oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 5 - (2,5-dioxotetrahydrofuranyl)-3-methyl-3-cyclohexane-1,2_ -29- 200948860 dicarboxylic dianhydride, tetracyclo[6,2,1,1,0, 2,7]癸-4,5,9,1〇-tetracarboxylic dianhydride, 3,5,6-tricarboxy-norbornane-2: 3,5:6-dicarboxylic dianhydride, 1,2 At least one selected from the group consisting of 4,5-cyclohexanetetracarboxylic dianhydride. The tetracarboxylic dianhydride may be used singly or in combination of two or more depending on the liquid crystal alignment property, voltage retention property, and accumulated electric charge when the liquid crystal alignment film is used. <Copolymer> The copolymer used in the present invention is polyglycine and polyimine. The polyamic acid is a polyamic acid obtained by reacting a diamine component ' containing a diamine compound (A) and a diamine compound (B) with a tetracarboxylic dianhydride. The polyimine of the present invention is a polyimine obtained by subjecting the polyamic acid to dehydration ring closure. Any of the polyamic acid and the polyimine is suitable as a copolymer of a liquid crystal alignment agent. The higher the content of the diamine compound (A) in the diamine component, the higher the voltage holding ratio, and after exposure to a high temperature for a long period of time, there is little residual charge accumulated by the DC voltage. Further, the diamine compound (B) has an effect of further improving the aforementioned effects. The content of the diamine compound (B) in the diamine component is preferably from 1 to 99 moles per gram of the amine compound (A). More preferably from 0.1 to 50 moles, the optimum is from 5 to 20 moles, and particularly preferably from 0.5 to 10 moles. The present invention can be used as a diamine component by using a diamine compound (A) or a diamine compound -30-200948860 other than the diamine compound (B) without impairing the effects of the present invention. The amount of the other diamine compound used at this time is preferably from 1 to 1 mol with respect to 1 mol of the diamine compound (A), more preferably from 0.1 to 5 mol. [Method for Producing Copolymer] The polylysine used in the present invention can be obtained by a known polymerization method. In general, for example, a method in which a tetracarboxylic dianhydride and a diamine component are reacted in an organic solvent. The reaction of the tetracarboxylic dianhydride with the diamine component is relatively easy to carry out in an organic solvent, and it is preferred that no by-products are produced. The organic solvent to be used at this time may be any solvent which can dissolve the produced polyamic acid. The following is a specific illustration thereof. Examples are hydrazine, hydrazine-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, dimethyl hydrazine, Tetramethyl urea, pyridine, dimethyl milling, hexamethylarylene, γ-butyrolactone, isopropanol, methoxymethylpentanol, dipentene, ethyl amyl ketone, methyl hydrazine Ketone 'methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, methyl cellosolve 'ethyl cellulolytic, methyl cellosolve acetate, ethyl cellosolve B Acid ester, butyl carbitol, ethyl carbitol, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol monoacetic acid Ester, propylene glycol monomethyl ether, propylene glycol tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol monoacetic acid Ester monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene di-31 - 200948860 alcohol monopropyl ether, dipropylene glycol monoacetate Monopropyl ether, 3-methyl-3-methoxybutyl B Acid ester, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, amyl acetate, butyl butyrate, butyl ether , diisobutyl ketone, methylcyclohexene, propyl ether, dihexyl ether, dioxane, n-hexane, n-pentane, n-octane, diethyl ether, cyclohexanone, ethylene carbonate, carbonic acid Propylene ester, methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol monoethyl ether, methyl pyruvate, ethyl pyruvate, methyl 3-methoxypropionate , 3-ethoxypropionic acid methyl ethyl ester, 3-methoxypropionic acid ethyl ester, 3-ethoxypropionic acid, 3-methoxypropionic acid, 3-methoxypropionic acid propyl ester, 3 - butyl methoxypropionate, diglyme, 4-hydroxy-4-methyl-2-pentanone, and the like. These may be used singly or in combination. Further, even a solvent in which polylysine cannot be dissolved can be used in the above solvent without being precipitated in the range in which the produced polyaminic acid is not precipitated. Further, since the water in the organic solvent hinders the polymerization reaction and further causes hydrolysis of the produced polylysine, it is preferred that the organic solvent be dried as much as possible. When the tetracarboxylic dianhydride and the diamine component are reacted in an organic solvent, for example, a solution obtained by stirring or dissolving a diamine component in an organic solvent, and directly adding a tetracarboxylic dianhydride, or making it a method of dispersing or dissolving in an organic solvent; and conversely adding a diamine component to a solution obtained by dispersing or dissolving a tetracarboxylic dianhydride in an organic solvent; and simultaneously adding tetracarboxylic dianhydride and two Any of these methods may be used as the method of the amine component. Further, when the tetracarboxylic dianhydride or the diamine component is composed of a plurality of kinds of compounds, the reaction may be carried out in a state of being mixed beforehand, or may be reacted in a sequence of -32 to 200948860, and the individual reaction may be carried out. The low molecular weight body is mixed and reacted into a high molecular weight body. The polymerization reaction of the polyamide can be selected from -20 ° C to 15 (any temperature of TC, but preferably in the range of -5 ° C to l ° ° C. In addition, the reaction can be arbitrary At the concentration, it is difficult to obtain a high molecular weight copolymer because the concentration is too low. When the concentration is too high, the viscosity of the reaction liquid is too high, so that uniform stirring becomes difficult, so the reaction of the tetracarboxylic dianhydride with the diamine component is dissolved. The total concentration in the φ liquid is preferably from 1 to 50% by mass, more preferably from 5 to 30% by mass. The initial stage of the reaction can be carried out at a high concentration, and then an organic solvent is further added. In the synthesis reaction of poly-proline The molar content of the diamine component is preferably from 0.8 to 1.2 with respect to 1 mole of the tetracarboxylic dianhydride. The closer the molar ratio is to 1.0, the molecular weight of the formed polyamine can be increased. The polyimine used in the present invention is a polyimine obtained by subjecting the above polyamic acid to dehydration ring closure, which can be used as a polymer for producing a liquid crystal alignment film. ◎ In the polyimine used in the present invention, The dehydration ring closure ratio of the proline group (the imidization ratio) is not necessarily 100%, depending on the use. The purpose of making the arbitrarily adjusted. The method for imidizing the polyruthenium imidate is exemplified by the heat-imidization of the solution of the poly-proline acid directly, and the catalyst added to the solution of the poly-proline The temperature at which the hydrazine imidization in the polyamic acid solution is from 100 ° C to 40 ° C, preferably from 120 ° C to 250, and preferably the hydrazine imidization reaction - 33- 200948860 The water produced is excluded from the system. The catalyst of imide can be imidized by adding a basic catalyst and an acid anhydride to the solution of poly-proline, and preferably at -20 to 250 °C. It is carried out by stirring at a temperature of 180 ° C. The amount of the alkaline catalyst is 0.5 to 30 moles, preferably 2 to 20 moles, of the prolyl group, and the amount of the anhydride is 1 of the amidate group. Up to 5 〇 moles, preferably 3 to 30 moles. As the basic catalyst, pyridine, triethylamine, trimethylamine, tributylamine, trioctylamine, etc., among them, The pyridine is preferred because it can maintain a moderate basicity to allow the reaction to proceed. The acid anhydride can be exemplified by acetic anhydride, trimellitic anhydride, benzene tetracarboxylic anhydride, etc., wherein the reaction is terminated if an acid anhydride is used. The subsequent purification becomes easier and preferable. The imidization ratio of the imidization of the catalyst oxime can be controlled by adjusting the amount of the catalyst, the reaction temperature, and the reaction time. Among the polyimine used in the present invention, The dehydration ring closure ratio (protonation rate) of the proline group is not necessarily 1%, and can be adjusted arbitrarily according to the purpose or purpose. The optimum is more than 50%. From polyglycine or polyimine When the reaction solution recovers the poly-proline or polyimine produced, the reaction solution can be poured into a weak solvent to form a precipitate. The weak solvent used for the precipitation can be exemplified by methanol, acetone, hexane, butyl cellosolve. , heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, water, etc. Pour into a weak solvent and the polymer of the Shen Dian is recovered by filtration and can be used under normal pressure or reduced pressure. , dry at room temperature or heat. Further, the precipitate-recovered polymer is redissolved in an organic solvent, and the reprecipitation recovery operation is repeated 2 to 10 times to reduce impurities in the polymer. The weak solvent at this time is exemplified by, for example, an alcohol, a ketone, a hydrocarbon, etc., and if three or more kinds of weak solvents selected from the group are used, it is preferable because the purification efficiency can be further improved. The molecular weight of the poly-proline and the polyimine contained in the liquid crystal alignment agent of the present invention is determined by GPC in consideration of the strength of the coating film obtained therefrom and the workability at the time of formation of the coating film, and the uniformity of the coating film. The weight average molecular weight measured by the (gel permeation chromatography) method is preferably 5,000 to 1,000,000, more preferably 10,000 S 1 50,000 ° 0 &lt;Liquid crystal alignment agent&gt; The liquid crystal alignment agent of the present invention is used for producing a liquid crystal alignment film. The coating liquid is composed of a resin component which forms a resin film and an organic solvent which dissolves the resin component. In the present invention, the resin component is a resin component containing a copolymer of at least one selected from the group consisting of polylysine and polyimine used in the present invention. In this case, the content of the resin component in the coating liquid is from 1% by mass to 20% by mass, preferably from 2% by mass to 10% by mass. In the present invention, the above-mentioned resin components may be all of the copolymers used in the present invention, or those in which the other polymers are mixed in the copolymer of the present invention. At this time, the content of the other polymer in the resin component is from 0.5% by mass to 15% by mass, preferably from 1% by mass to 10% by mass%. The other polymer, for example, a polyamine or a polyamine obtained by using a diamine compound (A) and a diamine other than the diamine compound (B) as a diamine component reactive with a tetracarboxylic dianhydride component醯imine and so on. The organic solvent used in the liquid crystal alignment agent of the present invention is not particularly limited as long as it can dissolve the organic solvent of the above resin component. Specifically, for example, -35-200948860 is listed below. For example, N,N-dimethylformamide, hydrazine, hydrazine-dimethylacetamide, N-methyl-2-pyrrolidone, hydrazine-methyl caprolactam, 2-pyrrolidone, Ν-ethyl pyrrolidone, Ν-vinyl pyrrolidone, dimethyl sulfoxide, tetramethyl urea, pyridine, dimethyl milling, hexamethyl argon, γ-butyrolactone, 1,3 - Dimethyl-imidazolidinone, ethyl amyl ketone, methyl decyl ketone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, cyclohexanone, ethylene carbonate, propylene carbonate Ester, diglyme, 4-hydroxy-4-methyl-2-pentanone, and the like. These solvents may be used in combination of two or more kinds. When the polyimine is dissolved in an organic solvent, it can be heat-treated for the purpose of promoting the dissolution of the polyimide. When the heating temperature is too high, the molecular weight of the polyimine will be lowered. Therefore, the temperature is preferably from 30 to 100 ° C. The liquid crystal alignment agent of the present invention may contain other components than the above. The solvent or compound which can improve the uniformity of the film thickness or the surface smoothness when the liquid crystal alignment agent is applied, and the compound which improves the adhesion between the liquid crystal alignment film and the substrate can be exemplified. Examples of the solvent (weak solvent) for improving film thickness uniformity or surface smoothness are as follows. Examples are, for example, isopropanol, methoxymethylpentanol, methyl cellosolve, ethyl cellosolve, butyl cellosolve, methyl cellosolve acetate, ethyl cellosolve acetate, butyl Kikabi alcohol, ethyl carbitol, ethyl carbitol acetate, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol , propylene glycol monoacetate, propylene glycol monomethyl ether, -36- 200948860 propylene glycol tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol II Methyl ether, dipropylene glycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol single Acetate monopropyl ether, 3-methyl-3-methoxybutyl acetate, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, B Isobutyl butyl ether, diisobutylene, amyl acetate, butyl butyrate, butyl ether, diisobutyl ketone oxime, methyl cyclohexene, propyl ether, dihexyl ether, 1-hexanol, n-hexane ,positive Alkane, n-octane, diethyl ether, methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol monoethyl ether, methyl pyruvate, ethyl pyruvate, 3 -methyl methoxypropionate, methyl ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, 3-methyl Propyl oxypropionate, butyl 3-methoxypropionate, 1-methoxy-2-propanol, 1-ethoxy-2-propanol, butyoxy-2-propanol, 1 -phenoxy-2-propanol, propylene glycol monoacetate, propylene glycol diacetate, propylene glycol-1-monomethyl ether-2-acetate, propylene glycol-1-monoethyl ether-2-ethyl a solvent having a low surface tension such as an acid ester, dipropylene glycol, 2-(2-ethoxypropoxy)propanol, methyl lactate, ethyl lactate, n-propyl lactate, n-butyl lactate or isoamyl lactate Wait. Among these solvents, butyl cellosolve, propylene glycol monomethyl ether, and ethyl lactate are preferred. These weak solvents may be used singly or in combination of plural kinds. When the solvent is as described above, it is preferably from 5 to 80% by mass, more preferably from 20 to 60% by mass, based on the total of the solvent contained in the liquid crystal alignment agent. -37-200948860 The compound which improves the uniformity after film or the surface smoothness is exemplified by a fluorine-based surfactant, a ruthenium-based surfactant, a nonionic surfactant, and the like. More specifically, for example, F TOP EF301, EF3 03, EF352 (manufactured by TOKEMU PRODUCT), MEGAFAX F171, F173, R-30 (manufactured by Dainippon Ink Co., Ltd.), FLUORAD FC430, FC431 (manufactured by Sumitomo 3M), ASAHIGUARD AG710, SURFLON S-382 'SC101, SC102, SC103, SC104, SC105, SC106 (made by Asahi Glass Co., Ltd.). The use ratio of the surfactants is preferably from 1 to 2 parts by mass, more preferably from 0.01 to 1 part by mass, per part by mass of the resin component contained in the liquid crystal alignment agent. Specific examples of the compound which improves the adhesion between the liquid crystal alignment film and the substrate are the functional decane-containing compound or the epoxy group-containing compound shown below. For example, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2-aminopropyltriethoxydecane, N - (2-Aminoethyl)-3-aminopropyltrimethoxydecane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxydecane, 3-ureido Propyltrimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-aminopropyltrimethoxydecane, N-ethoxycarbonyl-3-aminopropyl Triethoxy decane, N-triethoxydecyl propyl triethylidene triamine, N-trimethoxydecyl propyl triethylidene triamine, trimethoxy decyl _1, 4, 7 - triazadecane, 1 -triethoxydecyl-14,7-triazadecane, 9-trimethoxydecyl- 3,6-diazepine acetate, 9_ Triethoxy-38- 200948860-based alkyl-3,6-diazaindolyl acetate, N-benzyl-3-aminomethoxydecane, N-benzyl-3-aminopropyl three Ethoxy decane, &gt; 3-aminopropyltrimethoxydecane, N-phenyl-3-aminopropyltriethane, N-bis(oxyethyl)-3-aminopropyltrimethyl Oxydecane Ethyl ethyl-3-aminopropyl triethoxy decane, ethylene glycol dioleate, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl propylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, New φ diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol glyceryl ether, 2,2-dibromo neopentyl glycol diglycidyl ether, 1,3,5,6-glyceryl -2,4-hexanediol, ^:^', ^['-tetraglycidyl-m-diamine, 1,3-bis(indole, Ν-diglycidylamine 碁methyl) ring N, When N, N', N'-tetraglycidyl-4,4'-diaminodiphenylmethane or the like is used to improve the adhesion to a substrate, the resin component contained in the liquid crystal alignment agent is 100. The parts by mass are preferably 3 parts by mass, more preferably 1 to 20 parts by mass. If the amount used is less than 〇, the effect of improving the adhesion cannot be expected. If it is more than 30, the alignment of the liquid crystal may be deteriorated. In the liquid crystal alignment agent of the present invention, in addition to the above, a dielectric or a conductive material may be added for the purpose of changing the dielectric constant or the conductive electrical property of the liquid crystal alignment film within a range that does not impair the effect. Further, a crosslinkable compound which increases the hardness of the film or the purpose of the film as a liquid crystal alignment film may be added. &lt;Liquid crystal alignment film, liquid crystal display element&gt; Propyltriphenyl-oxyindole, N-bis-glycidyl ether, tripentanediol di-condensed tetra-xylene xylene hexane, and the amount of ruthenium relative to 0.1 to 0" mass The quality of the present invention and the nature of the hair, etc. -39-200948860 The liquid crystal alignment agent of the present invention is applied to a substrate and fired, and then subjected to alignment treatment by rubbing treatment or light irradiation, or in vertical alignment use or the like. It can be used as a liquid crystal alignment film by alignment treatment. In this case, the substrate to be used is not particularly limited as long as it is a substrate having high transparency, and a glass substrate, a plastic substrate such as an acrylic substrate or a polycarbonate substrate, or the like can be used. Further, from the viewpoint of simplification of the process, it is preferable to use a substrate which forms an ITO electrode or the like which is useful for driving the liquid crystal. Further, it is also possible to use an opaque material such as a tantalum wafer which is a single-sided substrate of the reflective liquid crystal display element, and a material such as aluminum which can reflect light can be used as the electrode. The coating method of the liquid crystal alignment agent is not particularly limited, and industrially, it is generally a method of screen printing, lithography, flexographic printing, ink jet printing or the like. As for other coating methods, there are dip coating, roll coating, slit coating, spin coating, etc., and these may be used depending on the purpose. The liquid crystal alignment agent is applied to the substrate and fired, and is heated at 50 to 300 ° C, preferably 80 to 250 ° C by a heating means such as a hot plate to evaporate the solvent to form a coating film. When the thickness of the coating film formed after firing is too thick, it is disadvantageous in terms of power consumption of the liquid crystal display element. If the thickness is too thin, the reliability of the liquid crystal display element may be lowered. Therefore, it is preferably 5 to 300 nm, more preferably 10 to l〇〇nm. When the liquid crystal is aligned horizontally or obliquely, the film after firing is treated by rubbing or polarized ultraviolet rays. The liquid crystal display element of the present invention is a substrate to which a liquid crystal alignment film is attached from the liquid crystal alignment agent of the present invention, and a liquid crystal cell is produced by a known method, and is used as a liquid crystal display element. For example, in the case of liquid crystal cell fabrication, one of the crystal-aligned films prepared to be formed with liquid - 40,488,480, and the substrate is disposed on the liquid crystal alignment film of one of the substrates, so that the liquid crystal alignment film surface becomes the inner side. In the method, another substrate is bonded, a liquid crystal is injected under reduced pressure, and the method is applied, or a method in which a liquid crystal is dropped on a liquid crystal alignment film surface on which a spacer is dispersed, and a substrate is bonded and packaged. The thickness of the separator at this time is preferably from 1 to 30 μm, more preferably from 2 to 10 μm. As described above, the liquid crystal display element produced by using the liquid crystal alignment agent of the present invention is excellent in reliability, and can be suitably used for a large-screen, high-definition liquid crystal television or the like. [Embodiment] [Embodiment] The present invention will be described in more detail below by way of examples and comparative examples, but the description of the present invention is not limited by the examples. The following are abbreviations and structural formulae for the compounds used in the examples. 〇(tetracarboxylic dianhydride) CBDA: 1,2,3,4•cyclobutane tetraresin dianhydride BODA:bicyclo[3,3,0 Octane-2,4,6,8-tetracarboxylic dianhydride [Chemical 29]

-41 - 200948860 PCH7DAB : 1,3-二胺基-4-〔 4· ( 4-庚基環己基)苯氧 基〕苯 DBA : 3,5-二胺基苯甲酸 2,4-DAA: 2,4-二胺基-叱&gt;^-二烯丙基苯胺-41 - 200948860 PCH7DAB : 1,3-Diamino-4-[ 4 · (4-heptylcyclohexyl)phenoxy]benzene DBA : 3,5-diaminobenzoic acid 2,4-DAA: 2 ,4-diamino-indole&gt;^-diallylaniline

Me-DADPA: N-甲基-4,4’-二胺基二苯基胺 二胺(1):(參考下述式) 二胺(2):(參考下述式) [化 30]Me-DADPA: N-methyl-4,4'-diaminodiphenylamine diamine (1): (refer to the following formula) Diamine (2): (refer to the following formula) [Chem. 30]

(有機溶劑) NMP: N -甲基-2-吡咯烷酮 BCS: 丁基溶纖素 &lt;分子量測定&gt; 合成例中之聚醯亞胺之分子量爲使用昭和電工公司製 常溫凝膠滲透色層分析法(GPC )裝置(GPC-101 )、 Shodex公司製管柱(KD-8 03、KD-805 )進行以下之測定 -42- 200948860(Organic solvent) NMP: N-methyl-2-pyrrolidone BCS: butyl cellulose &lt; molecular weight measurement&gt; The molecular weight of the polyimine in the synthesis example was a room temperature gel permeation chromatography method (manufactured by Showa Denko Co., Ltd.) GPC) device (GPC-101), Shodex company pipe column (KD-8 03, KD-805) for the following measurements -42- 200948860

管柱溫度:50°C 溶離液:N,N’-二甲基甲醯胺(添加劑爲溴化鋰一水 和物(LiBr · H20 )爲30mmol/L、磷酸.無水結晶(〇_磷 酸)爲 30mmol/L、四氫呋喃(THF)爲 l〇ml/L) 流速:1. Om 1/分 製作檢測線之標準樣品:東曹公司製 T S K標準氧化 聚乙烯(分子量 900,000、 150,000、 100,000、 30,000), 0 及,聚合物拉柏公司製聚乙二醇(分子量約12,000、 4,000 ' 1,000 ) ° &lt;醯亞胺化率之測定&gt; 合成例中之聚醯亞胺之醯亞胺化率係如下列般測定。 將20毫克之聚醯亞胺粉末加入NMR樣品管(草野科學公 司製造之NMR樣品管標準,Φ 5 )中’添加0.53毫升之 氘化二甲基亞碾(DMS0-d6 ’ 0.05%TMS (四甲基矽烷) Q 混合物),且以超音波使之完全溶解。該溶液使用日本電 子DATUM公司製造之NMR測定器(JNW-ECA500),測 定該溶液之5 00MHz之質子NMR。醯亞胺化率係使用源自 醯亞胺化前後未變化之結構之質子作爲基準質子予以決定 之該質子之峰估算値,及自9.5至1〇.〇ppm附近出現之來 自醯胺酸之NH基之質子峰之估算値,以下列之式求得。 醯亞胺化率(%) = (1-α · x/y)xl〇〇 上述式中,x爲源自醯胺酸之NH基之質子峰估算値 ,y爲基準質子峰估算値,α爲聚醯胺酸(醯亞胺化率爲 -43- 200948860 〇% )時相對於醯胺酸之NH基一個質子之基準質子之個數 比例。 &lt;合成例1 &gt; 將 BODA ( 18.8g,75mmol ) 、M e - D A D P A ( 6 · 3 g,Column temperature: 50 ° C Dissolution: N, N'-dimethylformamide (additive is lithium bromide monohydrate (LiBr · H20) is 30 mmol / L, phosphoric acid. Anhydrous crystal (〇 - phosphoric acid) is 30 mmol /L, tetrahydrofuran (THF) is l〇ml / L) Flow rate: 1. Om 1 / min. Standard sample for the test line: TSK standard oxidized polyethylene (molecular weight 900,000, 150,000, 100,000, 30,000) made by Tosoh Corporation, 0 And polyethylene glycol (manufactured by Labo Co., Ltd. (molecular weight: about 12,000, 4,000 '1,000) ° &lt;Measurement of oxime imidization ratio> The ruthenium imidization ratio of polyimine in the synthesis example is as follows Generally measured. Add 20 mg of the polyimine powder to the NMR sample tube (NMR sample tube standard manufactured by Kusano Scientific Co., Ltd., Φ 5 ) to add 0.53 ml of deuterated dimethyl sub-mill (DMS0-d6 '0.05% TMS (four Methyl decane) Q mixture), and completely dissolved by ultrasonic waves. This solution was subjected to proton NMR of 500 mM of this solution using a NMR measuring instrument (JNW-ECA500) manufactured by Nippon Electric Corporation. The ruthenium imidization ratio is a peak estimation of the proton determined by using a proton derived from an unaltered structure before and after the imidization as a reference proton, and a proline derived from 9.5 to 1 〇. The estimation of the proton peak of the NH group is obtained by the following formula.醯imination rate (%) = (1 - α · x / y) xl 〇〇 In the above formula, x is the proton peak estimate derived from the NH group of the proline, y is the reference proton peak estimate 値, α It is the ratio of the number of the protons of a proton relative to the NH group of the proline in the case of poly-proline (the imidization ratio is -43 to 200948860 〇%). &lt;Synthesis Example 1 &gt; BODA ( 18.8 g, 75 mmol), M e - D A D P A (6 · 3 g,

3 Ommo 1 ) 、DBA ( 6 . 1 g &gt; 40mmol ),及 PCH7D AB ( 1 1.4g ,30mmol)於NMP ( 114.0g)中混合,40°C下反應3小時 後,加入 CBDA ( 4.8g,25mmol )與 NMP ( 76.0g) ,4 0°C 下反應1 2小時後,得樹脂含量20質量%之聚醯胺酸溶液 [A]。該聚醯胺酸溶液之數平均分子量爲28,100、重量平 均分子量爲72,3 00。 &lt;合成例2&gt; 於合成例1所得聚醯胺酸溶液[A] ( 80. Og )中,加入 NMP稀釋至6質量%後,加入醯亞胺觸媒之乙酸酐(8.6g ),及吡啶(6.7g),使其於80 °C下反應3小時。將該反 應溶液投入甲醇(990ml )中,將所得沉澱物濾除。該沉 澱物使用甲醇洗淨,於100 °C下減壓乾燥,得聚醯亞胺粉 末[B]。該聚醯亞胺之醯亞胺化率爲53 %,數平均分子量 爲20,100、重量平均分子量爲58,300。 &lt;合成例3&gt; 將 BODA ( 1 8 · 8 g,7 5 m m ο 1 ) 、M e - D A D P A ( 6.3 g, 3 Ommol ) 、DBA ( 6.1g,40mmol ),及 P C H 7 D A B ( 1 1 · 4 g 200948860 ,30mmol )於 NMP ( 1 14.0g )中混合,於 40°C 下反應 3 小時後,加入 CBDA(4.8g,25mmol)與 NMP(76_0g) ,於40 °C下反應12小時,而製得聚醯胺酸溶液。 將該聚醯胺酸溶液(80.0g)加入NMP稀釋至6質量 %後,加入醯亞胺觸媒之乙酸酐(17.2g ) ’及吡啶( 13.3g),於90°C下反應3小時。將該反應溶液投入甲醇 (1 040ml )中,將所得沉澱物濾除。該沉澱物使用甲醇洗 φ 淨,於100°C下減壓乾燥,得聚醯亞胺粉末[C]。該聚醯亞 胺之醯亞胺化率爲81%,數平均分子量爲19,300、重量平 均分子量爲51,600。 &lt;合成例4&gt; 將 BODA ( 9.4g,37mmol )、二胺(1 ) ( 5.9g, 1 5mmo 1 ) 、DBA ( 3-0g,20mmol ),及 PCH7DAB ( 5.7g ,15mmol)於NMP (63.0g)中混合,使其於80°C下反應 ❿ 3 小時後,加入 CBDA(2.3g,12mmol)與 NMP(42.4g) ,於40 °C下反應12小時,而製得聚醯胺酸溶液。 將該聚醯胺酸溶液(5〇.〇g)加入NMP稀釋至6質量 %後,加入醯亞胺觸媒之乙酸酐(W.lg) ’及耻啶(3.9g ),於100°C下反應3小時。將該反應溶液投入甲醇( 6 5 0ml )中,將所得沉澱物濾除。該沉澱物使用甲醇洗淨 ,於100 °C下減壓乾燥,得聚醯亞胺粉末[D]。該聚醯亞胺 之醯亞胺化率爲53%,數平均分子量爲21,200、重量平均 分子量爲60,400。 -45- 200948860 &lt;合成例5&gt; 將 CBDA ( 9.7g,50mmol ) ' 2,4-DAA ( 2.0g, lOmmol) 、DBA ( 3.8g,25mmol ),及 PCH7DAB ( 5.7g ,15mmol)於 NMP(85.0g)中混合,於 23°C 下反應 20 小時,而製得聚醯胺酸溶液。 將該聚醯胺酸溶液(50.5g)加入NMP稀釋至6質量 %後,加入醯亞胺觸媒之乙酸酐(7.2g ),及吡啶(3.2g ),於50 °C下反應 3小時。將該反應溶液投入甲醇( 6 3 0ml )中,將所得沉澱物濾除。該沉澱物使用甲醇洗淨 ,於l〇〇t下減壓乾燥,得聚醯亞胺粉末[E]。該聚醯亞胺 之醯亞胺化率爲92%,數平均分子量爲1 8,700、重量平均 分子量爲46,400。 &lt;合成例6&gt; 將 BODA ( 7.5g,3 0 mm ο 1 ) 、DBA ( 3.7g,24mmol ) 、二胺(2) ( 2.8g,4.0mmol ),及 P C H 7 D AB ( 4 · 6 g, I2.0mmol)於NMP(49.2g)中混合,於80°C下反應5小 時後,力□入 CBDA( 1.9g,lO.Ommol) NMP(32.6g),於 4 0°C下反應3小時,而製得聚醯胺酸溶液。 將該聚醯胺酸溶液(50.0g)加入NMP稀釋至6質量 %後,加入醯亞胺觸媒之乙酸酐(5.0g ),及吡啶(3.7g ),於8 0 °C下反應2小時4 5分鐘。將該反應溶液投入甲 醇(600ml )中,將所得沉澱物濾除。該沉澱物使用甲醇 200948860 洗淨,於100°C下減壓乾燥’得聚醯亞胺粉末[F]。該聚醯 亞胺之醯亞胺化率爲50% ’數平均分子量爲20,800、重量 平均分子量爲60,200。 &lt;合成例7&gt; 將 BODA ( 150.1 g,600mmol ) 、DBA ( 60.9g, 400mmol ),及 P C Η 7 D A B ( 1 5 2 · 2 g,4 0 0 mm ο 1 )於 NMP ( φ 1290g )中混合,於80°C下反應5小時後,加入CBDA ( 38.8g,198mmol )與 NMP ( 320g ),於 40°C 下反應 3 小 時,而製得聚醯胺酸溶液。 將該聚醯胺酸溶液( 600.2g)加入NMP稀釋至6質 量%後,加入醯亞胺觸媒之乙酸酐(63.9g ),及吡啶( 49.6g),使其於80°C下反應3小時。將該反應溶液投入 甲醇(7700ml )中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨,於l〇〇°C下減壓乾燥,得聚醯亞胺粉末[G]。該聚 〇 醯亞胺之醯亞胺化率爲57%,數平均分子量爲23,000、重 量平均分子量爲80,200。 &lt;合成例8&gt; 將合成例7所得聚醯胺酸溶液(1〇1.2g)加入NMP 稀釋至6質量%後,加入醯亞胺觸媒之乙酸酐(21.3g), 及吡啶(16.5g) ’於90°C下反應3小時。將該反應溶液 投入甲醇(1300ml)中’將所得沉澱物濾除。該沉澱物使 用甲醇洗淨,於100 °C下減壓乾燥,得聚醯亞胺粉末[H]。 -47- 200948860 該聚醯亞胺之醯亞胺化率爲81%,數平均分子量爲20,400 、重量平均分子量爲63,000。 &lt;合成例9&gt; 將 CBDA ( 7.8g,40mmol ) 、2,4-D AA ( 4.9g ’ 24mmol ),及 PCH7DAB ( 6.1g,16mmol )於 NMP ( 74.9g)中混合,於23°C下反應20小時,而製得聚醯胺酸 溶液。 將該聚醯胺酸溶液(80.0g)加入NMP稀釋至6質量 %後,加入醯亞胺觸媒之乙酸酐(l〇.4g ),及吡啶(4.6g ),於50 °C下反應3小時。將該反應溶液投入甲醇( 1 0 00ml )中,將所得沉澱物濾除。該沉澱物使用甲醇洗淨 ,於100 °C下減壓乾燥,得聚醯亞胺粉末[I]。該聚醯亞胺 之醯亞胺化率爲97%’數平均分子量爲18,300、重量平均 分子量爲44,200。 200948860 [表l]3 Ommo 1 ) , DBA (6.1 g &gt; 40 mmol), and PCH7D AB (1 1.4 g, 30 mmol) were mixed in NMP (114.0 g), and reacted at 40 ° C for 3 hours, then CBDA (4.8 g, 25 mmol) and NMP (76.0 g) were reacted at 40 ° C for 12 hours to obtain a polyamine acid solution [A] having a resin content of 20% by mass. The polyamic acid solution had a number average molecular weight of 28,100 and an average weight molecular weight of 72,300. &lt;Synthesis Example 2&gt; In the polyamic acid solution [A] (80. Og) obtained in Synthesis Example 1, after adding NMP to 6% by mass, acetic anhydride (8.6 g) of a quinone imine catalyst was added, and Pyridine (6.7 g) was allowed to react at 80 ° C for 3 hours. The reaction solution was poured into methanol (990 ml), and the resulting precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder [B]. The polyimine had a ruthenium iodide ratio of 53%, a number average molecular weight of 20,100, and a weight average molecular weight of 58,300. &lt;Synthesis Example 3&gt; BODA (1 8 · 8 g, 7 5 mm ο 1 ), Me - DADPA (6.3 g, 3 Ommol), DBA (6.1 g, 40 mmol), and PCH 7 DAB (1 1 · 4 g 200948860, 30 mmol) was mixed in NMP (1 14.0 g), and after reacting at 40 ° C for 3 hours, CBDA (4.8 g, 25 mmol) and NMP (76-0 g) were added and reacted at 40 ° C for 12 hours. A polyaminic acid solution was prepared. After the polyacrylic acid solution (80.0 g) was added to NMP and diluted to 6 mass%, acetic anhydride (17.2 g) and pyridine (13. 3 g) of a ruthenium imine catalyst were added, and the mixture was reacted at 90 ° C for 3 hours. The reaction solution was poured into methanol (1 040 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain a polyimine powder [C]. The polyimine had a ruthenium iodide ratio of 81%, a number average molecular weight of 19,300, and an average weight molecular weight of 51,600. &lt;Synthesis Example 4&gt; BODA (9.4 g, 37 mmol), diamine (1) (5.9 g, 15 mmo 1 ), DBA (3-0 g, 20 mmol), and PCH7DAB (5.7 g, 15 mmol) in NMP (63.0) g) mixed, allowed to react at 80 ° C for 3 hours, then added CBDA (2.3 g, 12 mmol) and NMP (42.4 g), and reacted at 40 ° C for 12 hours to obtain a polyaminic acid solution. . After the polyaminic acid solution (5 〇.〇g) was added to NMP and diluted to 6 mass%, acetic anhydride (W.lg) ' and guanidine (3.9 g) of the quinone imine catalyst were added at 100 ° C. The reaction was carried out for 3 hours. The reaction solution was poured into methanol (650 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain a polyimine powder [D]. The polyimine had a hydrazine imidization ratio of 53%, a number average molecular weight of 21,200, and a weight average molecular weight of 60,400. -45- 200948860 &lt;Synthesis Example 5&gt; CBDA (9.7 g, 50 mmol) '2,4-DAA (2.0 g, 10 mmol), DBA (3.8 g, 25 mmol), and PCH7DAB (5.7 g, 15 mmol) in NMP ( The mixture was mixed in 85.0 g, and reacted at 23 ° C for 20 hours to prepare a polyaminic acid solution. After the polyproline solution (50.5 g) was added to NMP and diluted to 6 mass%, acetic anhydride (7.2 g) of ruthenium amide and pyridine (3.2 g) were added, and the mixture was reacted at 50 ° C for 3 hours. The reaction solution was poured into methanol (600 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 1 Torr to give a polyimine powder [E]. The polyimine had a hydrazine imidation ratio of 92%, a number average molecular weight of 1,800, and a weight average molecular weight of 46,400. &lt;Synthesis Example 6&gt; BODA (7.5 g, 30 mm ο 1 ), DBA (3.7 g, 24 mmol), diamine (2) (2.8 g, 4.0 mmol), and PCH 7 D AB (4 · 6 g) , I2.0mmol), mixed in NMP (49.2g), reacted at 80 ° C for 5 hours, then inject CBDA (1.9g, 10.Ommol) NMP (32.6g), react at 40 ° C 3 In hours, a polyaminic acid solution was prepared. After the polyaminic acid solution (50.0 g) was added to NMP and diluted to 6 mass%, acetic anhydride (5.0 g) of ruthenium amide was added, and pyridine (3.7 g) was added, and the reaction was carried out at 80 ° C for 2 hours. 45 minutes. The reaction solution was poured into methanol (600 ml), and the resulting precipitate was filtered. The precipitate was washed with methanol 200948860 and dried under reduced pressure at 100 ° C to obtain a polyimine powder [F]. The polyimine was imidized at a 50% yield average molecular weight of 20,800 and a weight average molecular weight of 60,200. &lt;Synthesis Example 7&gt; BODA (150.1 g, 600 mmol), DBA (60.9 g, 400 mmol), and PC Η 7 DAB (1 5 2 · 2 g, 400 mm ο 1 ) in NMP (φ 1290 g ) After mixing and reacting at 80 ° C for 5 hours, CBDA (38.8 g, 198 mmol) and NMP (320 g) were added and reacted at 40 ° C for 3 hours to obtain a polyaminic acid solution. After the polyaminic acid solution (600.2 g) was added to NMP and diluted to 6 mass%, acetic anhydride (63.9 g) of ruthenium amide catalyst and pyridine (49.6 g) were added, and the mixture was reacted at 80 ° C. hour. The reaction solution was poured into methanol (7700 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol and dried under reduced pressure at 10 ° C to obtain a polyimine powder [G]. The polyamidimide had a ruthenium iodide ratio of 57%, a number average molecular weight of 23,000, and a weight average molecular weight of 80,200. &lt;Synthesis Example 8&gt; The polyamic acid solution (1 〇 1.2 g) obtained in Synthesis Example 7 was added to NMP and diluted to 6 mass%, and then acetic anhydride (21.3 g) of ruthenium amide was added, and pyridine (16.5 g) was added. ) 'React at 90 ° C for 3 hours. The reaction solution was poured into methanol (1300 ml) to remove the resulting precipitate. The precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain a polyimine powder [H]. -47- 200948860 The polyamidimide has an imidization ratio of 81%, a number average molecular weight of 20,400, and a weight average molecular weight of 63,000. &lt;Synthesis Example 9&gt; CBDA (7.8 g, 40 mmol), 2,4-D AA (4.9 g '24 mmol), and PCH7DAB (6.1 g, 16 mmol) were mixed in NMP (74.9 g) at 23 ° C The reaction was carried out for 20 hours to prepare a polyaminic acid solution. After the polyaminic acid solution (80.0 g) was added to NMP and diluted to 6 mass%, acetic anhydride (10 g. 4 g) of ruthenium imide catalyst, and pyridine (4.6 g) were added, and the reaction was carried out at 50 ° C. hour. The reaction solution was poured into methanol (100 ml), and the resulting precipitate was filtered. The precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain a polyimine powder [I]. The polyimine was imidized at a 97%' number average molecular weight of 18,300 and a weight average molecular weight of 44,200. 200948860 [Table l]

合成 例 二胺成份[mmol: 四羧酸成份 [mmol] 醯亞胺 化率(%) 二胺化合物 (A) 二胺化雜 (Β) 其他 二胺 1 聚醯胺酸[A] Me-DADPA 『301 DBA[40] PCH7DAB P〇l CBDA[25] BODA「751 - 2 聚醯亞胺粉末[B] Me-DADPA Γ301 DBA[40] PCH7DAB [301 CBDA[25] ΒΟΟΑΓ751 53 3 聚醯亞胺粉末[C] Me-DADPA Γ301 DBA[40] PCH7DAB 『301 CBDA[25] ΒΟΟΑΓ751 81 4 聚醯亞胺粉末[D] 二胺⑴ Γ151 DBA[20] PCH7DAB Π51 CBDA[12] BODAP71 53 5 聚醯亞胺粉末[E] 2,4-DAA Π〇1 DBAP5] PCH7DAB [151 CBDA[50] 92 6 聚醯亞胺粉末[F] 二胺(2) [41 DBA[24] PCH7DAB 『121 CBDA[10] BODAPOl 50 7 聚醯亞胺粉末[G] - DBA[400] PCH7DAB 「4001 CBDA[198] BODA[60〇1 57 8 聚醯亞胺粉末[H] - DBA[400] PCH7DAB [4001 CBDA[198] BODA[60〇1 81 9 聚醯亞胺粉末[I] 2,4·ϋΑΑ Γ241 - PCH7DAB Γ161 CBDA[40] 97 表中,「二胺化合物(A )」之欄及「二胺化合物(B )」之欄中之「-」,係指並未使用該些二胺化合物之意 [本發明之液晶配向劑之製作·評估] &lt;實施例1&gt; 於合成例1所得聚醯胺酸溶液[A] ( 1 0 · 1 g )中,加入 NMP ( 8.1g ),及 BCS ( 16.0g ),經 2 5 °C 下攪拌 2 小時後 ,得液晶配向劑[1 ]。該液晶配向劑並未出現混濁或析出等 -49- 200948860 異常現象,確認樹脂成份呈均勻的溶解。 [液晶晶胞之製作] 將上述所得之液晶配向劑π]旋轉塗佈於附有 極之玻璃基板,80°C之熱壓板上乾燥5分鐘後,方 之熱風循環式烤箱進行1小時之燒焙,而製得膜厚 之液晶配向膜。準備2片附有該液晶配向膜之基相 1片之液晶配向膜面上散佈6μπι之調距器後,於姜 密封劑,經貼合後,使密封劑硬化以製作空晶胞。 胞晶使用減壓注入法,注入液晶MLC-6608 (美赛 本公司製),將注入口封閉,得向列型液晶晶胞。 [電壓保持率之評估] 對上述所製作之液晶晶胞,於80°C之溫度下 施加4V之電壓,測定16.67ms後,及1 667ms後: 以確定電壓究竟保持至何種程度以計算電壓保持S 測定爲使用東陽科技公司製VHR-1電壓保持率| ,以設定爲 Voltage : ±4V,Pulse Width : 60μδ Period : 16.67ms或1667ms下進行測定。其結果ί 表2所示。 [殘留電荷之評估] 對電壓保持率測定後之液晶晶胞,施加3 0 / 流電壓5 · 8 Vpp與直流電壓1 V,測定直流電壓解β ΙΤΟ電 2 1 0°C 1 0 0 nm ,於其 上印刷 該空晶 克•曰 以 60ps :電壓, ;。又, 丨定裝置 、Flame 〖如後述 時之交 後於液 -50- 200948860 晶晶胞內所發生之電壓(殘留電荷)。其結果係如後述表 3所示。 [高溫放置後之評估] 將上述測定結束之液晶晶胞,放置於設定於60°C之恆 溫槽中1〇日後,測定期電壓保持率及殘留電荷。其結果 係如後述表2及表3所示。 ❹ &lt;實施例2&gt; 於合成例2所得之聚醯亞胺粉末[B] ( 5.0g )中,加入 NMP ( 24.4g ),於70 °C下攪拌40小時使其溶解。於該溶 液中,加入 NMP(12.3g),及 BCS(41.7g),經 25°C 下 攪拌2小時後,得液晶配向劑[2]。該液晶配向劑並未出現 混濁或析出等異常現象,確認樹脂成份呈均勻的溶解。 使用所得之液晶配向劑[2],依實施例1相同方法製作 〇 液晶晶胞,並進行電壓保持率之評估、殘留電荷之評估、 高溫放置後之評估。其結果係如後述表2及表3所示。 &lt;實施例3&gt; 於合成例3所得之聚醯亞胺粉末[C](5.1g)中,加入 NMP ( 24.5g),於70 °C下攪拌40小時使其溶解。於該溶 液中,加入 NMP(23.9g),及 BCS(30.0g),經 25°C 下 攪拌2小時後,得液晶配向劑[3]。該液晶配向劑並未出現 混濁或析出等異常現象,確認樹脂成份呈均勻的溶解。 -51 - 200948860 使用所得之液晶配向劑[3],依實施例1相同方法製作 液晶晶胞,並進行電壓保持率之評估、殘留電荷之評估、 高溫放置後之評估。其結果係如後述表2及表3所示。 &lt;實施例4&gt; 於合成例4所得之聚醯亞胺粉末[D] ( 5.0g )中,加入 NMP ( 25.0g),於70 °C下攪拌40小時使其溶解。於該溶 液中,加入 NMP(20.1g),及 BCS(33.2g),經 25°C 下 攪拌2小時後,得液晶配向劑[4]。該液晶配向劑並未出現 混濁或析出等異常現象,確認樹脂成份呈均勻的溶解。 使用所得之液晶配向劑[4],依實施例1相同方法製作 液晶晶胞,並進行電壓保持率之評估、殘留電荷之評估、 高溫放置後之評估。其結果係如後述表2及表3所示。 &lt;實施例5 &gt; 於合成例5所得之聚醯亞胺粉末[E] ( 4.9g )中,加入 NMP ( 24.5g ),於70 °C下攪拌40小時使其溶解。於該溶 液中’加入 NMP(29.0g) ’ 及 BCS(25.3g),經 25°C 下 攪拌2小時後,得液晶配向劑[5]。該液晶配向劑並未出現 混濁或析出等異常現象,確認樹脂成份呈均勻的溶解。 使用所得之液晶配向劑[5],依實施例1相同方法製作 液晶晶胞,並進行電壓保持率之評估、殘留電荷之評估、 高溫放置後之評估。其結果係如後述表2及表3所示。 -52- 200948860 &lt;實施例6&gt; 於合成例6所得之聚醯亞胺粉末[F] ( 5.0g )中’加入 NMP ( 25.0g ),於70 °C下攪拌40小時使其溶解。於該溶 液中,加入 NMP(11.5g),及 BCS(42.9g),經 25°C 下 攪拌2小時後,得液晶配向劑[6]。該液晶配向劑並未出現 混濁或析出等異常現象,確認樹脂成份呈均勻的溶解。 使用所得之液晶配向劑[6],依實施例1相同方法製作 0 液晶晶胞,並進行電壓保持率之評估、殘留電荷之評估、 高溫放置後之評估。其結果係如後述表2及表3所示。 &lt;比較例1 &gt; 於合成例7所得之聚醯亞胺粉末[G] ( 5.0g )中,加入 NMP ( 25.0g),於70°C下攪拌40小時使其溶解。於該溶 液中’加入 NMP(23.1g),及 BCS(28.5g),經 25°C 下 攪拌2小時後,得液晶配向劑[7]。該液晶配向劑並未出現 〇 混濁或析出等異常現象,確認樹脂成份呈均勻的溶解。 使用所得之液晶配向劑[7],依實施例1相同方法製作 液晶晶胞,並進行電壓保持率之評估、殘留電荷之評估、 高溫放置後之評估。其結果係如後述表2及表3所示。 &lt;比較例2 &gt; 於合成例8所得之聚醯亞胺粉末[H] ( 5 · 1 g )中’加入 NMP ( 25.0g ),於701:下攪拌40小時使其溶解。於該溶 液中,加入 NMP(30.4g),及 BCS(23.3g),經 25°C 下 -53- 200948860 攪拌2小時後,得液晶配向劑[8]。該液晶配向劑並未出現 混濁或析出等異常現象,確認樹脂成份呈均勻的溶解。 使用所得之液晶配向劑[8] ’依實施例1相同方法製作 液晶晶胞,並進行電壓保持率之評估、殘留電荷之評估、 高溫放置後之評估。其結果係如後述表2及表3所示。 &lt;比較例3 &gt; 於合成例9所得之聚醯亞胺粉末[I] ( 5 . 1 g )中,加入 NMP ( 24.8g ),於70 °C下攪拌40小時使其溶解。於該溶 液中,加入 NMP(36.4g),及 BCS(17.3g),經 25°C 下 攪拌2小時後,得液晶配向劑[9]。該液晶配向劑並未出現 混濁或析出等異常現象,確認樹脂成份呈均勻的溶解。 使用所得之液晶配向劑[9],依實施例1相同方法製作 液晶晶胞,並進行電壓保持率之評估、殘留電荷之評估、 高溫放置後之評估。其結果係如後述表2及表3所示。 又,表2及表3中,醯亞胺化率之「-」係指並未算 出醯亞胺化率之意。 -54- 200948860 [表2] 液晶配向劑 醯亞胺化率(%) 電壓保持率(%) 液晶晶1 剛乍時 高雛置後 16.67ms 1667ms 16.67ms 1667ms 實施例1 [1] - 96.9 56.8 96.7 56.5 實施例2 [2] 53 98.1 65.9 98.0 66.0 實施例3 [3] 81 98.0 66.7 98.0 66.7 實施例4 [4] 53 97.8 68.5 97.7 68.4 實施例5 [5] 92 97.9 69.0 97.9 68.9 實施例ό Γ61 50 97.1 55.2 97.0 55.1 比較例1 [7] 57 97.8 64.5 97.5 64.3 比較例2 [8] 81 97.6 61.2 97.3 61.0 比較例3 「91 97 97.8 61.9 97.5 61.4 液晶配向劑 醯亞胺化率(%) 殘留電1 苛(V) 液晶晶胞製作時 高雛置後 實施例1 [1] - 0.01 0.01 實施例2 [2] 53 0.02 0.03 實施例3 [3] 81 0.02 0.05 實施例4 [4] 53 0.03 0.06 實施例5 [5] 92 0.05 0.08 實施例6 [61 50 0.02 0.03 比較例1 [7] 57 0.15 0.25 比較例2 [8] 81 0.24 0.41 比較例3 Γ91 97 0.16 0.21 [表3] [產業上之利用性] 本發明之液晶配向劑’可得電壓保持率高且即使且於 長時間暴露於高溫下之後亦僅有少許因直流電壓引起之殘 留電荷之液晶配向膜。因此方式所得之液晶顯示元件’即 -55- 200948860 使長時間使用時,也可抑制畫面之燒附或顯示斑等顯示不 良之狀態,故可成爲具有優良信賴性之配向劑,而極適用 於大畫面且高精細度之液晶電視等。其結果,極適合用於 TN元件、STN元件、TFT液晶元件,進而可用於垂直配 向型或水平配向型(IPS )之液晶顯示元件等。 又,2008年1月25日申請之日本特願2008-014973 號之說明書、申請專利範圍,及摘要之全部內容均被引用 ,且倂入本發明之說明書之揭示內容中。Synthesis Example Diamine Component [mmol: Tetracarboxylic Acid Component [mmol] Ruthenium Amination Rate (%) Diamine Compound (A) Diamidation (Β) Other Diamine 1 Polyamine Acid [A] Me-DADPA 301 DBA[40] PCH7DAB P〇l CBDA[25] BODA"751 - 2 Polyimine powder [B] Me-DADPA Γ301 DBA[40] PCH7DAB [301 CBDA[25] ΒΟΟΑΓ751 53 3 Polyimine powder [C] Me-DADPA Γ301 DBA[40] PCH7DAB 『301 CBDA[25] ΒΟΟΑΓ751 81 4 Polyimine powder [D] Diamine (1) Γ151 DBA[20] PCH7DAB Π51 CBDA[12] BODAP71 53 5 Polyimine Powder [E] 2,4-DAA Π〇1 DBAP5] PCH7DAB [151 CBDA[50] 92 6 Polyimine powder [F] Diamine (2) [41 DBA[24] PCH7DAB 『121 CBDA[10] BODAPOl 50 7 Polyimine powder [G] - DBA[400] PCH7DAB "4001 CBDA[198] BODA[60〇1 57 8 Polyimine powder [H] - DBA[400] PCH7DAB [4001 CBDA[198] BODA [60〇1 81 9 Polyimine powder [I] 2,4·ϋΑΑ Γ241 - PCH7DAB Γ161 CBDA[40] 97 In the table, "diamine compound (A)" and "diamine compound (B)" "-" in the column means the meaning of not using these diamine compounds [Liquid of the present invention Preparation and evaluation of crystal alignment agent] &lt;Example 1&gt; NMP (8.1 g) and BCS (16.0 g) were added to the polyamine acid solution [A] (1 0 · 1 g) obtained in Synthesis Example 1. After stirring at 25 ° C for 2 hours, a liquid crystal alignment agent [1 ] was obtained. The liquid crystal alignment agent did not exhibit turbidity or precipitation, etc. -49-200948860 Anomaly, and it was confirmed that the resin component was uniformly dissolved. [Production of Liquid Crystal Cell] The liquid crystal alignment agent π] obtained above was spin-coated on a glass substrate with a pole attached thereto, and dried on a hot plate at 80 ° C for 5 minutes, and then subjected to a hot air circulating oven for 1 hour. After baking, a film thickness liquid crystal alignment film is obtained. After preparing a 6 μm-sized distance aligner on the liquid crystal alignment film surface of the liquid crystal alignment film with the liquid crystal alignment film, the sealant was hardened to form an empty cell. The cell crystal was injected into a liquid crystal MLC-6608 (manufactured by Messen Co., Ltd.) using a reduced pressure injection method, and the injection port was closed to obtain a nematic liquid crystal cell. [Evaluation of Voltage Retention Rate] For the liquid crystal cell fabricated above, a voltage of 4 V was applied at a temperature of 80 ° C, after 16.67 ms, and after 1 667 ms: to determine the degree to which the voltage was maintained to calculate the voltage. The S measurement was measured by using the VHR-1 voltage holding ratio | by the Dongyang Technology Co., Ltd., and the measurement was performed under the conditions of Voltage: ±4 V, Pulse Width: 60 μδ Period : 16.67 ms or 1667 ms. The result ί is shown in Table 2. [Evaluation of residual charge] For the liquid crystal cell after the voltage holding ratio is measured, apply 3 0 /current voltage 5 · 8 Vpp and DC voltage 1 V, and measure DC voltage solution β ΙΤΟ electricity 2 1 0 ° C 1 0 0 nm, Print the empty crystal on it at 60ps: voltage, ; In addition, the voltage device (residual charge) generated in the cell of the liquid -50-200948860 after the intersection of the device and the film is described later. The results are shown in Table 3 below. [Evaluation after high-temperature standing] The liquid crystal cell after completion of the above measurement was placed in a constant temperature bath set at 60 ° C for 1 day, and the voltage holding ratio and residual charge were measured during the measurement period. The results are shown in Tables 2 and 3 below. ❹ &lt;Example 2&gt; NMP (24.4 g) was added to the polyimine powder [B] (5.0 g) obtained in Synthesis Example 2, and the mixture was stirred at 70 ° C for 40 hours to be dissolved. NMP (12.3 g) and BCS (41.7 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment agent [2]. The liquid crystal alignment agent did not exhibit an abnormal phenomenon such as turbidity or precipitation, and it was confirmed that the resin component was uniformly dissolved. Using the obtained liquid crystal alignment agent [2], a ruthenium liquid crystal cell was produced in the same manner as in Example 1, and evaluation of voltage holding ratio, evaluation of residual charge, and evaluation after high temperature standing were performed. The results are shown in Tables 2 and 3 below. &lt;Example 3&gt; NMP (24.5 g) was added to the polyimine powder [C] (5.1 g) obtained in Synthesis Example 3, and the mixture was stirred at 70 ° C for 40 hours to be dissolved. NMP (23.9 g) and BCS (30.0 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment agent [3]. The liquid crystal alignment agent did not exhibit an abnormal phenomenon such as turbidity or precipitation, and it was confirmed that the resin component was uniformly dissolved. -51 - 200948860 Using the obtained liquid crystal alignment agent [3], a liquid crystal cell was produced in the same manner as in Example 1, and evaluation of voltage holding ratio, evaluation of residual charge, and evaluation after high temperature standing were performed. The results are shown in Tables 2 and 3 below. &lt;Example 4&gt; NMP (25.0 g) was added to the polyimine powder [D] (5.0 g) obtained in Synthesis Example 4, and the mixture was stirred at 70 ° C for 40 hours to be dissolved. NMP (20.1 g) and BCS (33.2 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment agent [4]. The liquid crystal alignment agent did not exhibit an abnormal phenomenon such as turbidity or precipitation, and it was confirmed that the resin component was uniformly dissolved. Using the obtained liquid crystal alignment agent [4], a liquid crystal cell was produced in the same manner as in Example 1, and evaluation of voltage holding ratio, evaluation of residual charge, and evaluation after high temperature standing were performed. The results are shown in Tables 2 and 3 below. &lt;Example 5&gt; NMP (24.5 g) was added to the polyimine powder [E] (4.9 g) obtained in Synthesis Example 5, and the mixture was stirred at 70 ° C for 40 hours to be dissolved. NMP (29.0 g) and BCS (25.3 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment agent [5]. The liquid crystal alignment agent did not exhibit an abnormal phenomenon such as turbidity or precipitation, and it was confirmed that the resin component was uniformly dissolved. Using the obtained liquid crystal alignment agent [5], a liquid crystal cell was produced in the same manner as in Example 1, and evaluation of voltage holding ratio, evaluation of residual charge, and evaluation after high temperature standing were performed. The results are shown in Tables 2 and 3 below. -52-200948860 &lt;Example 6&gt; NMP (25.0 g) was added to the polyimine powder [F] (5.0 g) obtained in Synthesis Example 6, and the mixture was stirred at 70 ° C for 40 hours to be dissolved. NMP (11.5 g) and BCS (42.9 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment agent [6]. The liquid crystal alignment agent did not exhibit an abnormal phenomenon such as turbidity or precipitation, and it was confirmed that the resin component was uniformly dissolved. Using the obtained liquid crystal alignment agent [6], a liquid crystal cell was prepared in the same manner as in Example 1, and evaluation of voltage holding ratio, evaluation of residual charge, and evaluation after high temperature standing were performed. The results are shown in Tables 2 and 3 below. &lt;Comparative Example 1 &gt; NMP (25.0 g) was added to the polyimine powder [G] (5.0 g) obtained in Synthesis Example 7, and the mixture was stirred at 70 ° C for 40 hours to be dissolved. NMP (23.1 g) and BCS (28.5 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment agent [7]. The liquid crystal alignment agent did not exhibit an abnormal phenomenon such as turbidity or precipitation, and it was confirmed that the resin component was uniformly dissolved. Using the obtained liquid crystal alignment agent [7], a liquid crystal cell was produced in the same manner as in Example 1, and evaluation of voltage holding ratio, evaluation of residual charge, and evaluation after high temperature standing were performed. The results are shown in Tables 2 and 3 below. &lt;Comparative Example 2 &gt; NMP (25.0 g) was added to the polyimine powder [H] (5 · 1 g ) obtained in Synthesis Example 8 and stirred at 701: for 40 hours to be dissolved. To the solution, NMP (30.4 g) and BCS (23.3 g) were added, and after stirring at -53 to 200948860 at 25 ° C for 2 hours, a liquid crystal alignment agent [8] was obtained. The liquid crystal alignment agent did not exhibit an abnormal phenomenon such as turbidity or precipitation, and it was confirmed that the resin component was uniformly dissolved. Using the obtained liquid crystal alignment agent [8]', a liquid crystal cell was produced in the same manner as in Example 1, and evaluation of voltage holding ratio, evaluation of residual charge, and evaluation after high temperature standing were performed. The results are shown in Tables 2 and 3 below. &lt;Comparative Example 3 &gt; In the polyimine powder [I] (5.1 g) obtained in Synthesis Example 9, NMP (24.8 g) was added, and the mixture was stirred at 70 ° C for 40 hours to be dissolved. NMP (36.4 g) and BCS (17.3 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment agent [9]. The liquid crystal alignment agent did not exhibit an abnormal phenomenon such as turbidity or precipitation, and it was confirmed that the resin component was uniformly dissolved. Using the obtained liquid crystal alignment agent [9], a liquid crystal cell was produced in the same manner as in Example 1, and evaluation of voltage holding ratio, evaluation of residual charge, and evaluation after high temperature standing were performed. The results are shown in Tables 2 and 3 below. Further, in Tables 2 and 3, the "-" of the imidization ratio means that the imidization ratio is not calculated. -54- 200948860 [Table 2] Liquid crystal alignment agent 醯 imidization rate (%) Voltage retention rate (%) Liquid crystal crystal 1 After the high entanglement 16.67 ms 1667 ms 16.67 ms 1667 ms Example 1 [1] - 96.9 56.8 96.7 56.5 Example 2 [2] 53 98.1 65.9 98.0 66.0 Example 3 [3] 81 98.0 66.7 98.0 66.7 Example 4 [4] 53 97.8 68.5 97.7 68.4 Example 5 [5] 92 97.9 69.0 97.9 68.9 Example Γ Γ 61 50 97.1 55.2 97.0 55.1 Comparative Example 1 [7] 57 97.8 64.5 97.5 64.3 Comparative Example 2 [8] 81 97.6 61.2 97.3 61.0 Comparative Example 3 "91 97 97.8 61.9 97.5 61.4 Liquid crystal alignment agent 醯 imidization ratio (%) Residual electricity 1 When the harsh (V) liquid crystal cell is produced at a high level, Example 1 [1] - 0.01 0.01 Example 2 [2] 53 0.02 0.03 Example 3 [3] 81 0.02 0.05 Example 4 [4] 53 0.03 0.06 Example 5 [5] 92 0.05 0.08 Example 6 [61 50 0.02 0.03 Comparative Example 1 [7] 57 0.15 0.25 Comparative Example 2 [8] 81 0.24 0.41 Comparative Example 3 Γ91 97 0.16 0.21 [Table 3] [Industrial Utilizing] The liquid crystal alignment agent of the present invention has a high voltage holding ratio and is small even after exposure to a high temperature for a long period of time. A liquid crystal alignment film which has a residual electric charge due to a DC voltage. Therefore, when the liquid crystal display element obtained by the method, that is, -55-200948860, can be used for a long period of time, it is possible to suppress a display failure such as burnt or display of a picture, so that it can become It has excellent reliability of the alignment agent, and is very suitable for large-screen and high-definition LCD TVs. As a result, it is very suitable for TN components, STN components, TFT liquid crystal components, and can be used for vertical alignment or horizontal alignment. The liquid crystal display element of (IPS), etc. The entire contents of the specification, the scope of the patent application, and the abstract of the Japanese Patent Application No. 2008-014973, filed on Jan. Reveal the content.

-56--56-

Claims (1)

200948860 七、申請專利範圍: 1· 一種液晶配向劑’其特徵爲含有,包含二胺化合 物(A)及二胺化合物(B)之二胺成份與四殘酸二酐反應 所得之共聚物, 二胺化合物(A):下述之具有三級氮原子之二胺化 合物之由式[T1]、式[T2]及式[T3]所成群中所選出之至少 一種之化合物, φ 二胺化合物(B):分子內具有羧基之二胺化合物, [化1]200948860 VII. Patent application scope: 1. A liquid crystal alignment agent characterized by containing a copolymer obtained by reacting a diamine component of a diamine compound (A) and a diamine compound (B) with a tetrahydro acid dianhydride, Amine compound (A): a compound of at least one selected from the group consisting of the formula [T1], the formula [T2] and the formula [T3] of the diamine compound having a tertiary nitrogen atom, φ diamine compound (B): a diamine compound having a carboxyl group in the molecule, [Chemical Formula 1] [τι] [T2] H2N_〇^4^W4^^_n H2 [T3] (式[T1]至式[T3]中,Wi爲苯環或含氮芳香族雜環, W2爲具有6至15個碳原子,且具有1至2個苯環之芳香 族基,W3爲碳數2至5之伸烷基或聯苯撐,W4爲可被3 級氮原子所取代之碳原子數4至6之伸環烷基,W5爲碳 數2至5之伸烷基,Zl爲,Wi爲苯環之情形時爲碳數1 至6之可被脂肪族基所取代之二取代胺基,Wi爲含氮芳 香族雜環之情形時爲可被氫原子或碳數1至6之脂肪族基 所取代之二取代胺基,Z2爲碳數1至5之烷基或苯環,g 爲〇或1之整數)。 2.如申請專利範圍第1項之液晶配向劑,其中,二 胺化合物(A)爲下述之式[1]至式[4]所表示之化合物, -57- 200948860 [化2] /A·) h2n[τι] [T2] H2N_〇^4^W4^^_n H2 [T3] (In the formula [T1] to the formula [T3], Wi is a benzene ring or a nitrogen-containing aromatic heterocyclic ring, and W2 has 6 to 15 One carbon atom and having 1 to 2 aromatic groups of a benzene ring, W3 is an alkylene group or a biphenyl group having 2 to 5 carbon atoms, and W4 is a carbon atom 4 to 6 which may be substituted by a nitrogen atom of 3 a cycloalkyl group, W5 is an alkylene group having 2 to 5 carbon atoms, and Z1 is a disubstituted amino group having a carbon number of 1 to 6 which may be substituted by an aliphatic group in the case where Wi is a benzene ring, Wi is In the case of a nitrogen-containing aromatic heterocyclic ring, it is a disubstituted amino group which may be substituted by a hydrogen atom or an aliphatic group having 1 to 6 carbon atoms, Z2 is an alkyl group having 1 to 5 carbon atoms or a benzene ring, and g is ruthenium or An integer of 1). 2. The liquid crystal alignment agent of the first aspect of the invention, wherein the diamine compound (A) is a compound represented by the following formula [1] to formula [4], -57- 200948860 [Chemical 2] /A ·) h2n [2] [3] [1][2] [3] [1] [4] [4a] [4b][4] [4a] [4b] (式[1]至式[4]中’ Ai爲含氮芳香族雜環’ A2爲具有 6至15個碳原子’且具有1至2個苯環之芳香族基,A3 爲碳數2至5之伸烷基或聯苯撐,A4爲式[4a]或式[4b]所 表示之基,A5爲碳數2至5之伸烷基’Υι爲碳數1至6 之脂肪族基所取代之二取代胺基,Y2爲碳數1至5之烷基 或苯環,k爲0或1之整數)。(In the formula [1] to the formula [4], Ai is a nitrogen-containing aromatic heterocyclic ring 'A2 is an aromatic group having 6 to 15 carbon atoms' and having 1 to 2 benzene rings, and A3 is a carbon number 2 to An alkyl group or a biphenylene group, A4 is a group represented by the formula [4a] or the formula [4b], and A5 is an aliphatic group having a carbon number of 2 to 5 and an alkyl group having a carbon number of 1 to 6. Substituted disubstituted amine group, Y2 is an alkyl group having 1 to 5 carbon atoms or a benzene ring, and k is an integer of 0 or 1. 3 _如申請專利範圍第2項之液晶配向劑’其中’二 胺化合物(A)爲式[丨]或式[2]。 4 ·如申請專利範圍第2項之液晶配向劑,其中’式 [3]之A2爲苯環或下述之式[3a], [化3] [3a] (式[3a]中,p爲由單鍵、-〇_、-NH-、伸甲基’及酿 胺基所選出之鍵結基)。 -58- 200948860 5.如申請專利範圍第1或2項之液晶配向劑,其中 ’二胺化合物(A)爲由下述之式[5]至[is]所成群所選出 之至少一種之二胺化合物,3 _ The liquid crystal alignment agent of the second aspect of the patent application ' wherein the 'diamine compound (A) is of the formula [丨] or the formula [2]. 4. The liquid crystal alignment agent of claim 2, wherein A2 of the formula [3] is a benzene ring or the following formula [3a], [Chemical 3] [3a] (in the formula [3a], p is A bonding group selected from a single bond, -〇_, -NH-, methyl-methyl and aramidyl). -58-200948860 5. The liquid crystal alignment agent of claim 1 or 2, wherein the 'diamine compound (A) is at least one selected from the group consisting of the following formulas [5] to [is] Diamine compound, [化4][Chemical 4] [化5][Chemical 5] [13][13] [化6][Chemical 6] [17] [18] -59- 200948860 (式[13]中,m、η分別爲1至11之整數,m + n爲2 至12之整數’式[15]中’ j爲〇至3之整數’式[18]中’ h 爲1至5之整數)。 6.如申請專利範圍第1至5項中任一項之液晶配向 劑,其中,二胺化合物(B)爲下述之式[19]所表示之二 胺化合物, [19][17] [18] -59- 200948860 (in [13], m and η are integers from 1 to 11, respectively, and m + n is an integer from 2 to 12 in the formula [15] where 'j is 〇 to 3 In the integer 'in the formula [18], 'h is an integer from 1 to 5). 6. The liquid crystal alignment agent according to any one of claims 1 to 5, wherein the diamine compound (B) is a diamine compound represented by the following formula [19], [19] [化7] (|〇OH) n /I、 Η〆 NH2 (式[19]中’ Χι爲碳數6至30之具有芳香族環之有 機基,η爲1至4之整數)。 7.如申請專利範圍第6項之液晶配向劑,其中,二 胺化合物(Β )爲由下述之式[20]至式[24]所選出之二胺化 合物, [化8](|〇OH) n /I, Η〆 NH2 (In the formula [19], Χ is an organic group having an aromatic ring of 6 to 30 carbon atoms, and η is an integer of 1 to 4). 7. The liquid crystal alignment agent of claim 6, wherein the diamine compound (Β) is a diamine compound selected from the following formula [20] to formula [24], [Chem. 8] Η2Ν-|· -j-(C〇〇H)in1 [2 0]Η2Ν-|· -j-(C〇〇H)in1 [2 0] ~ 60 - 200948860 (式[2 0]中’ ml爲1至4之整數’式[2丨]中,χ2爲單 鍵、-(:112-、-。2114-、-€:(€:113)2-、-〇?2-、-(:(。?3)2-、-0- 、-CO-、-ΝΗ-、-N(CH3)-、-CONH-、-NHC〇-、_cH2〇_、· OCH2-、-COO-、-OCO-、-CON(CH3)_,或-n(CH3)CO-, m2、m3分別爲〇至4之整數’且m2 + m3表示i至4之整 數,式[22]中’ m4、m5分別爲1至5之整數,式[23]中, φ X3爲碳數1至5之直鏈或支鏈烷基,m6爲1至5之整數 、式[24]中,X4 爲單鍵、_CH2-、-C2H4-、_C(CH3)2-、 -cf2-、-c(cf3)2-、-o-、-co-、-nh-、-n(ch3)-、-conh- 、-NHCO-、-CH20-、-OCH2-、-COO-、-OCO-、 -CON(CH3)- ’ 或-N(CH3)CO-,in7 爲 1 至 4 之整數)。 8. 如申請專利範圍第7項之液晶配向劑,其中,式 [20]中,ml爲1至2之整數。 9. 如申請專利範圍第7項之液晶配向劑’其中’式 ⑩ [2 1 ]中,X2 爲單鍵、-CH2-、-C2H4-、-C(CH3)2-、-Ο-、 -CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-COO-,或 -OCO-,m2、m3同時爲1之整數。 10. 如申請專利範圍第7項之液晶配向劑’其中’式 [24]中,X4 爲單鍵、-CH2-、-〇-、-CO·、-NH-、-CONH· 、-NHCO-、-CH20.、_OCH2-、-COO-,或-OCO-,m7 爲 1 至2之整數。 1 1.如申請專利範圍第1至1 0項中任一項之液晶配 向劑,其中,二胺成份中之二胺化合物(B )之含量爲相 -61 - 200948860 對於二胺化合物(A)之1莫耳,爲〇〇1至99莫耳。 1 2 .如申請專利範圍第1至1 1項中任一項之液晶配 向劑’其中,液晶配向劑中所含之溶劑中之5至8 0質量% 爲弱溶劑。 1 3 ·如申請專利範圍第丨至1 2項中任一項之液晶配 向劑’其中’液晶配向劑中之共聚物爲聚醯胺酸經脫水閉 環所得之聚醯亞胺。 14. 一種液晶配向膜,其特徵爲,使用申請專利範圍 第1至1 3項中任一項之液晶配向劑所得者。 15. —種液晶顯示元件,其特徵爲,具有申請專利範 圍第14項之液晶配向膜。 -62- 200948860 四、指定代表圖: (一) 、本案指定代表圖為:無 (二) 、本代表圖之元件代表符號簡單說明:無 ❹ 五、本案若有化學式時,請揭示最能顯示發明特徵的化學 式:化1 (化1)~ 60 - 200948860 (in the formula [2 0] 'ml is an integer from 1 to 4' in the formula [2丨], χ2 is a single bond, -(:112-, -.2114-, -€:(€:113 ) 2-, -〇?2-, -(:(.?3)2-,-0-, -CO-, -ΝΗ-, -N(CH3)-, -CONH-, -NHC〇-, _cH2 〇_, · OCH2-, -COO-, -OCO-, -CON(CH3)_, or -n(CH3)CO-, m2, m3 are integers from 〇 to 4, respectively, and m2 + m3 represents i to 4 In the formula [22], m4 and m5 are each an integer from 1 to 5, and in the formula [23], φ X3 is a linear or branched alkyl group having a carbon number of 1 to 5, and m6 is an integer of 1 to 5. In the formula [24], X4 is a single bond, _CH2-, -C2H4-, _C(CH3)2-, -cf2-, -c(cf3)2-, -o-, -co-, -nh-, -n(ch3)-, -conh-, -NHCO-, -CH20-, -OCH2-, -COO-, -OCO-, -CON(CH3)-' or -N(CH3)CO-,in7 is 1 8. The liquid crystal alignment agent of claim 7, wherein in the formula [20], ml is an integer of 1 to 2. 9. The liquid crystal alignment agent of claim 7 Where 'Formula 10 [2 1 ], X2 is a single bond, -CH2-, -C2H4-, -C(CH3)2-, -Ο-, -CO-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -COO- Or -OCO-, m2, m3 are both an integer of 1. 10. In the liquid crystal alignment agent of the seventh aspect of the patent application, in the formula [24], X4 is a single bond, -CH2-, -〇-, - CO·, -NH-, -CONH· , -NHCO-, -CH20., _OCH2-, -COO-, or -OCO-, m7 is an integer from 1 to 2. 1 1. Patent application range 1 to 1 The liquid crystal alignment agent of any one of the items 0, wherein the content of the diamine compound (B) in the diamine component is phase -61 - 200948860, and 1 mole of the diamine compound (A) is 〇〇1 to 99. The liquid crystal alignment agent of any one of the liquid crystal alignment agents, wherein 5 to 80% by mass of the solvent contained in the liquid crystal alignment agent is a weak solvent. 1 3 · The liquid crystal alignment agent of any one of the inventions of the invention, wherein the copolymer in the liquid crystal alignment agent is a polyimine obtained by dehydration ring closure of polyamic acid. It is characterized in that the liquid crystal alignment agent of any one of claims 1 to 13 is used. A liquid crystal display element characterized by having a liquid crystal alignment film of claim 14 of the patent application. -62- 200948860 IV. Designated representative drawings: (1) The representative representative of the case is: No (2), the representative symbol of the representative figure is a simple description: no flaws 5. If there is a chemical formula in this case, please reveal the best display. Chemical formula of the invention: Chemical 1 (Chemical 1) -4--4-
TW98103132A 2008-01-25 2009-01-23 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element TWI438226B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008014973 2008-01-25

Publications (2)

Publication Number Publication Date
TW200948860A true TW200948860A (en) 2009-12-01
TWI438226B TWI438226B (en) 2014-05-21

Family

ID=40901212

Family Applications (1)

Application Number Title Priority Date Filing Date
TW98103132A TWI438226B (en) 2008-01-25 2009-01-23 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Country Status (5)

Country Link
JP (1) JP5177150B2 (en)
KR (1) KR101589322B1 (en)
CN (1) CN101925850B (en)
TW (1) TWI438226B (en)
WO (1) WO2009093709A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI556042B (en) * 2012-11-07 2016-11-01 Jsr股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5492516B2 (en) * 2009-10-01 2014-05-14 株式会社ジャパンディスプレイ Liquid crystal display
JP5387428B2 (en) * 2010-01-26 2014-01-15 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
WO2011132752A1 (en) * 2010-04-22 2011-10-27 日産化学工業株式会社 Liquid-crystal alignment agent, liquid-crystal alignment film, and liquid-crystal display element
KR101829939B1 (en) * 2010-06-10 2018-02-19 닛산 가가쿠 고교 가부시키 가이샤 Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
JP5537345B2 (en) * 2010-09-03 2014-07-02 株式会社ジャパンディスプレイ Liquid crystal display
CN102445790B (en) 2010-10-06 2016-05-18 株式会社日本显示器 Alignment films, composition for forming alignment film and liquid crystal indicator
JP5771948B2 (en) * 2010-10-28 2015-09-02 日産化学工業株式会社 Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element
JP5786501B2 (en) * 2011-07-01 2015-09-30 Jsr株式会社 Color filter, liquid crystal display element, and method of manufacturing color filter
TWI485489B (en) * 2011-07-27 2015-05-21 Nissan Chemical Ind Ltd Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
JP2013105063A (en) * 2011-11-15 2013-05-30 Jsr Corp Liquid crystal aligning agent, and liquid crystal display element
JP5874590B2 (en) * 2011-12-26 2016-03-02 Jsr株式会社 Liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, polymer and compound
JP5962381B2 (en) * 2011-12-27 2016-08-03 Jsr株式会社 Liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element and polymer
JP6179261B2 (en) * 2012-11-07 2017-08-16 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
WO2014148440A1 (en) * 2013-03-19 2014-09-25 日産化学工業株式会社 Liquid crystal aligning agent for in-plane switching
JP6361168B2 (en) * 2013-06-17 2018-07-25 Jsr株式会社 Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, method for producing liquid crystal display element, polymer and compound
WO2015050135A1 (en) * 2013-10-01 2015-04-09 日産化学工業株式会社 Liquid crystal aligning agent for in-plate switching, liquid crystal alignment film and liquid crystal display element using same
JPWO2015050133A1 (en) * 2013-10-01 2017-03-09 日産化学工業株式会社 Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element using the same
JP6315193B2 (en) 2013-10-03 2018-04-25 Jsr株式会社 Liquid crystal alignment agent
JP6492564B2 (en) * 2014-02-13 2019-04-03 Jsr株式会社 Liquid Crystal Alignment Agent, Liquid Crystal Alignment Film, Liquid Crystal Display Element, Retardation Film, Method of Producing Retardation Film, Polymer, and Compound
JP6315182B2 (en) * 2014-03-18 2018-04-25 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
JP5759042B2 (en) * 2014-04-25 2015-08-05 株式会社ジャパンディスプレイ Alignment film material for liquid crystal
JP6447209B2 (en) * 2014-05-12 2019-01-09 Jsr株式会社 Polymer composition, liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, and method for producing liquid crystal display element
WO2016080458A1 (en) * 2014-11-21 2016-05-26 Jnc株式会社 Liquid crystal aligning agent containing polyamic acid or derivative thereof, liquid crystal alignment film and liquid crystal display element
JP6572912B2 (en) * 2014-12-25 2019-09-11 日産化学株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR102420192B1 (en) * 2016-06-14 2022-07-12 닛산 가가쿠 가부시키가이샤 Liquid crystal aligning agent and liquid crystal display element for application of BOA substrates or substrates with BCS
WO2018062438A1 (en) * 2016-09-29 2018-04-05 日産化学工業株式会社 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
KR102465496B1 (en) * 2016-09-29 2022-11-09 닛산 가가쿠 가부시키가이샤 A liquid crystal aligning agent, a liquid crystal aligning film, and a liquid crystal display element
WO2018216664A1 (en) * 2017-05-22 2018-11-29 日産化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
CN107400360A (en) * 2017-06-28 2017-11-28 徐昌霞 A kind of microelectronic device polyimides/aluminium nitride hybridized film and preparation method thereof
CN111263913B (en) * 2017-10-25 2023-03-28 日产化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
JPWO2021070714A1 (en) * 2019-10-07 2021-04-15
CN115380244A (en) 2020-03-30 2022-11-22 日产化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
WO2022014345A1 (en) * 2020-07-14 2022-01-20 日産化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2691212B2 (en) * 1989-08-10 1997-12-17 日本合成ゴム株式会社 Liquid crystal alignment agent
JPH03261915A (en) * 1990-03-13 1991-11-21 Japan Synthetic Rubber Co Ltd Liquid crystal orienting agent
JP3069922B2 (en) * 1991-05-13 2000-07-24 東洋通信機株式会社 Force transmission mechanism
JPH05249473A (en) * 1992-03-06 1993-09-28 Seiko Epson Corp Oriented film and liquid crystal display body
JP3201172B2 (en) 1994-09-08 2001-08-20 ジェイエスアール株式会社 Liquid crystal alignment agent
JP3261915B2 (en) * 1995-03-13 2002-03-04 松下電器産業株式会社 Tracking control device
JP3613421B2 (en) 1996-05-31 2005-01-26 Jsr株式会社 Liquid crystal alignment agent
JP3650982B2 (en) 1996-10-02 2005-05-25 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
KR101148812B1 (en) * 2003-11-26 2012-05-30 닛산 가가쿠 고교 가부시키 가이샤 Liquid crystal alignment treating agent for vertical alignment and liquid crystal display
JP4779974B2 (en) * 2004-12-22 2011-09-28 日産化学工業株式会社 Liquid crystal aligning agent and liquid crystal display element using the same
CN101057178B (en) * 2004-12-28 2010-06-02 日产化学工业株式会社 Liquid-crystal alignment material for vertical alignment, liquid-crystal alignment film, and liquid-crystal display element employing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI556042B (en) * 2012-11-07 2016-11-01 Jsr股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Also Published As

Publication number Publication date
CN101925850A (en) 2010-12-22
KR101589322B1 (en) 2016-01-27
CN101925850B (en) 2012-06-06
JP5177150B2 (en) 2013-04-03
JPWO2009093709A1 (en) 2011-05-26
WO2009093709A1 (en) 2009-07-30
TWI438226B (en) 2014-05-21
KR20100103583A (en) 2010-09-27

Similar Documents

Publication Publication Date Title
TW200948860A (en) Liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element
JP6561833B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI477478B (en) Diamine compounds, polyamic acid, polyimide and liquid crystal alignment treatment agent
JP6152914B2 (en) Novel dicarboxylic acid anhydride and process for producing the same
JP6233309B2 (en) Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element
TWI591098B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW200944553A (en) Liquid-crystal alignment material and liquid-crystal display element
TWI564344B (en) A method for preparing a polyimide varnish, and a liquid crystal aligning agent
JPWO2016140288A1 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP6065074B2 (en) Diamine compounds, polyimide precursors and polyimides
JP2020073680A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TW201030056A (en) Liquid crystal aligning agent and liquid crystal display element using same
JP6217937B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TW200841093A (en) Agent for alignment treatment of liquid crystal and liquid crystal display element using the same
TW201219380A (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
JP6183616B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JPWO2018097155A1 (en) Liquid crystal display element manufacturing method, liquid crystal display element substrate, and liquid crystal display element assembly
JPWO2018025872A1 (en) Liquid crystal display device having liquid crystal panel having curved surface shape and liquid crystal alignment agent therefor
TW201030058A (en) Liquid crystal aligning agent and liquid crystal element using same
TWI494374B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same
JPWO2014024892A1 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI683857B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element